Quarterly Report • Aug 9, 2018
Quarterly Report
Open in ViewerOpens in native device viewer
Summary 3 Financial highlights 4 Overview of results and balance sheet 5 Analysis of the quarter 6 Analysis of the year-to-date period 8 Risk statement, economic views and guidance 9 Annex 10
Consolidated income statement 12 Consolidated statement of comprehensive income 14 Consolidated balance sheet 15 Consolidated statement of changes in equity 16 Consolidated cash flow statement 18 Notes on statement of compliance and changes in accounting policies 18 Summary of significant accounting policies 20 Transition disclosures IFRS 9 20 Notes on segment reporting 21 Other notes 22 Additional information
Credit risk 35 Solvency 41 Income statement, volumes and ratios per business unit 44 Details of ratios and terms 52
'I, Rik Scheerlinck, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
Investor Relations contact details [email protected] KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 9 August 2018
Check this document's authenticity at www.kbc.com/en/authenticity .
Report for 2Q2018
| KBC Group - overview (consolidated, IFRS) | 2Q2018 (IFRS 9) |
1Q2018 (IFRS 9) |
2Q2017 (IAS 39) |
1H2018 (IFRS9) |
1H2017 (IAS39) |
|---|---|---|---|---|---|
| Net result (in millions of EUR) | 692 | 556 | 855 | 1 248 | 1 485 |
| Basic earnings per share (in EUR) | 1.61 | 1.30 | 2.01 | 2.91 | 3.49 |
| Breakdown of the net result by business unit (in millions of EUR) | |||||
| Belgium | 437 | 243 | 483 | 680 | 785 |
| Czech Republic | 145 | 171 | 183 | 316 | 364 |
| International Markets | 163 | 137 | 177 | 299 | 292 |
| Group Centre | -53 | 5 | 12 | -48 | 45 |
| Parent shareholders' equity per share (in EUR, end of period) | 39.9 | 40.9 | 39.8 | 39.9 | 39.8 |
We recorded a net profit of 692 million euros in the second quarter of 2018. Yet again a good result, thanks, among other things, to a sound level of net interest income, a strong non-life insurance result and seasonally high dividend income, which partly offset the decrease in trading and fair value income, the slight drop in fee and commission income and the negative one-off impact related to the settlement of a legacy legal case. Given seasonal effects, costs remained under control and moreover, we were able yet again to release some loan loss provisions, mainly related to our Irish mortgage book. Adding the result for the second quarter to the 556-million-euro net profit figure for the previous quarter brings our result for the first half of 2018 to a solid 1 248 million euros. Our solvency position remained strong too, with a common equity ratio of 15.8% at the end of June 2018, comfortably surpassing the regulatory minimum levels in this respect.
In April, we successfully issued a new additional tier-1 instrument for an amount of 1 billion euros. And early July, we completed our announced buyback of 2.7 million own shares for a total consideration of 181 million euros. The cancellation of these shares has reduced the total number of KBC Group shares to 415 897 567. Lastly, in line with our dividend policy, we decided to pay an interim dividend of 1 euro per share on 16 November 2018, as an advance payment on the total dividend for 2018.
We also took important new steps in the implementation of our sustainability strategy. In May, for instance, KBC – as promoter – became the first financial institution in the Belgian market to launch an SRI pension savings fund. The fund in question is managed by KBC Asset Management and is fully compliant with BEAMA sustainability criteria. In June, we published our stricter policies for sustainable banking and insurance and in doing so, are responding to the constantly evolving expectations of our stakeholders and the wider community. And again in June, we were the first Belgian financial institution to launch a green bond.
On the broader economic front, European economic conditions have remained attractive, though we believe that the growth peak is likely behind us. The risk of further economic de-globalisation, with an escalation of trade conflicts, remains the main factor that could impede European economic growth.
In closing, I'd like to take this opportunity again to thank our clients and other stakeholders for the trust they place in our company and our employees, and to repeat that we remain fully committed and focused in our efforts to become the reference in bank-insurance in all our core countries.
I'm also pleased to announce that KBC Bank Ireland reached an agreement with Goldman Sachs to sell a part (approximately 1.9 billion euros) of its legacy loan portfolio. As a result of that transaction, KBC Bank Ireland's impaired loans ratio reduces by roughly 11 percentage points to around 25% pro forma at end 2Q2018. The transaction is expected to result in a net profit
impact of +14 million euros (based on 1Q2018 numbers and including all costs related to the transaction), a release of risk-weighted assets of approximately 0.4 billion euros at KBC Group, leading to an improvement of the KBC Group common equity ratio of 7 bps. The transaction is expected to close in the 4th quarter of 2018.
Johan Thijs Chief Executive Officer
Important. As of 2018, we have started applying IFRS 9. In simplified terms, this means that the classification of financial assets and liabilities, as well as the impairment methodology, have changed significantly. As a result, some of the profit and loss and balance sheet figures are not fully comparable to the 2017 reference figures (which are still based on IAS 39, as KBC is making use of transition relief for comparative data). In order to enhance transparency, we have also, as of 2018 and in line with IFRS 9, moved interest accruals for FX derivatives in the banking book from 'fair value income' to 'net interest income'. We also shifted network income (income received from margins earned on FX transactions carried out by the network for our customers) from 'trading and fair value income' to 'net fee and commission'. A short overview is provided in the annex. Furthermore, related to IFRS 9, we changed, as of 2018, the definition of our loan portfolio from outstanding to gross carrying amount (i.e. incl. reserved and accrued interests) and slightly amended the scope. In order to enhance comparability, we have added certain comparisons with pro forma (recalculated) figures for 2017 (unaudited) in the analysis below. When this is done, it is indicated by the words 'on a comparable basis'.
Our strategy rests on four principles:
| Consolidated income statement, IFRS KBC Group (in millions of EUR) |
2Q2018 (IFRS 9) |
1Q2018 (IFRS 9) |
4Q2017 (IAS 39) |
3Q2017 (IAS 39) |
2Q2017 (IAS 39) |
1H2018 (IFRS 9) |
1H2017 (IAS 39) |
|---|---|---|---|---|---|---|---|
| Net interest income | 1 117 | 1 125 | 1 029 | 1 039 | 1 028 | 2 242 | 2 052 |
| Non-life insurance (before reinsurance) | 202 | 162 | 152 | 188 | 179 | 364 | 366 |
| Earned premiums Technical charges |
392 -190 |
378 -216 |
384 -232 |
378 -190 |
369 -190 |
770 -406 |
729 -363 |
| Life insurance (before reinsurance) | 1 | -7 | -3 | -3 | -24 | -5 | -52 |
| Earned premiums Technical charges |
315 -314 |
336 -343 |
410 -414 |
282 -284 |
267 -291 |
651 -656 |
579 -631 |
| Ceded reinsurance result | -14 | -9 | -10 | 16 | -10 | -23 | -13 |
| Dividend income | 34 | 21 | 8 | 11 | 30 | 55 | 44 |
| Net result from financial instruments at fair value through P&L1 |
54 | 96 | 235 | 182 | 249 | 150 | 439 |
| Net realised result from available-for-sale assets | - | - | 51 | 51 | 52 | - | 97 |
| Net realised result from debt instruments at fair value | 8 | 1 | - | - | - | 9 | - |
| through other comprehensive income Net fee and commission income |
438 | 450 | 430 | 408 | 430 | 889 | 869 |
| Other net income | 23 | 71 | -14 | 4 | 47 | 94 | 124 |
| 1 863 | 1 912 | 1 878 | 1 896 | 1 980 | 3 775 | 3 926 | |
| Total income | |||||||
| Operating expenses | -966 | -1 291 | -1 021 | -914 | -910 | -2 257 | -2 139 |
| Impairment Of which: on loans and receivables2 |
1 - |
56 - |
-2 30 |
-31 -15 |
71 78 |
58 - |
64 72 |
| Of which: on financial assets at amortised cost and at fair value through other comprehensive income2 |
21 | 63 | - | - | - | 84 | - |
| Share in results of associated companies & joint ventures | 3 | 6 | -5 | 8 | 3 | 10 | 8 |
| Result before tax | 901 | 683 | 850 | 959 | 1 144 | 1 585 | 1 858 |
| Income tax expense | -210 | -127 | -451 | -268 | -288 | -337 | -373 |
| Result after tax | 692 | 556 | 398 | 691 | 855 | 1 248 | 1 485 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 692 | 556 | 399 | 691 | 855 | 1 248 | 1 485 |
| Basic earnings per share (EUR) | 1.61 | 1.30 | 0.92 | 1.62 | 2.01 | 2.91 | 3.49 |
| Diluted earnings per share (EUR) | 1.61 | 1.30 | 0.92 | 1.62 | 2.01 | 2.91 | 3.49 |
| Key consolidated balance sheet figures KBC Group (in millions of EUR) |
30-06-2018 (IFRS 9) |
31-03-2018 (IFRS 9) |
31-12-2017 (IAS 39) |
30-09-2017 (IAS 39) |
30-06-2017 (IAS 39) |
||
| Total assets | 301 934 | ||||||
| 304 022 | 292 342 | 296 885 | 296 479 | ||||
| Loans and advances to customers, excl. reverse repos | 145 346 | 142 512 | 140 999 | 139 538 | 138 522 | ||
| Securities (equity and debt instruments) | 63 936 | 66 050 | 67 743 | 69 273 | 70 898 | ||
| Deposits from customers and debt certificates, excl.repos | 192 951 | 188 034 | 193 708 | 188 962 | 188 708 | ||
| Technical provisions, before reinsurance | 18 595 | 18 754 | 18 641 | 18 696 | 18 905 | ||
| Liabilities under investment contracts, insurance | 13 428 | 13 338 | 13 552 | 13 294 | 13 339 | ||
| Parent shareholders' equity | 16 616 | 17 119 | 17 403 | 17 003 | 16 665 | ||
| Selected ratios | 1H2018 | FY2017 | |||||
| KBC group (consolidated) | |||||||
| Return on equity Cost/income ratio, banking |
16% | 17% | |||||
| (when excluding certain non-operating items and evenly spreading | 62% (56%) |
54% (55%) |
|||||
| the bank tax) Combined ratio, non-life insurance |
88% | 88% | |||||
| Common equity ratio, Basel III Danish Compromise (fully loaded) |
15.8% | 16.3% | |||||
| Common equity ratio, FICOD (fully loaded) | 15.0% | 15.1% | |||||
| Leverage ratio, Basel III (fully loaded) | 6.0% | 6.1% | |||||
| Credit cost ratio3 | -0.10% | -0.06% | |||||
| Impaired loans ratio | 5.5% | 6.0% | |||||
| for loans more than 90 days past due | 3.2% | 3.4% | |||||
| Net stable funding ratio (NSFR) | 136% | 134% | |||||
| Liquidity coverage ratio (LCR) 1 Also referred to as 'trading and fair value income'. |
139% | 139% |
3 A negative figure indicates a net impairment release (with a positive impact on the results).
We provide a full overview of our IFRS consolidated income statement and balance sheet in the 'Consolidated financial statements' section of the quarterly report. Condensed statements of comprehensive income, changes in shareholders' equity, as well as several notes to the accounts, are also available in the same section. As regards the (changes in) definition of ratios, see 'Details of ratios and terms' in the quarterly report.
Total income Total income was slightly down (-3%) quarter-on-quarter. Overall, net interest income was relatively stable (-1%), non-life insurance income and dividend income increased, net fee and commission income fell slightly and trading and fair value income dropped 1 863 million euros significantly. Net other income was adversely impacted by a one-off item.
Net interest income amounted to 1 117 million euros in the quarter under review. On a comparable basis, it was relatively stable quarter-on-quarter (-1%), but up year-on-year (+2%). In general, the pressure on commercial loan margins in most core countries, the negative effect of low reinvestment yields and a lower netted positive impact of ALM forex swaps were offset by loan volume growth, lower funding costs, higher repo rates in the Czech Republic and the consolidation of UBB/Interlease (year-on-year). As already mentioned, interest income continued to be supported by loan volume growth: the total volume of customer lending rose by 3% quarter-on-quarter and by 5% year-on-year, with increases in all business units. Customer deposits including debt certificates went up by 3% quarter-on-quarter, and by 2% year-on-year. Excluding debt certificates (which were down year-onyear due to several factors, including the lower level of certificates of deposits and repayment of the contingent capital securities in January), deposits went up by 6% year-on-year, again with increases in all business units. The net interest margin came to 2.00% for the quarter under review, down 1 basis point and up 4 basis points on the level in the previous and year-earlier quarter, respectively.
Our non-life insurance activities did very well, contributing 189 million euros to technical insurance income (earned premiums less technical charges, plus the ceded reinsurance result), 24% more than in the previous quarter and 11% more year-on-year. While the quarter-on-quarter increase was accounted for by the combination of increased premium income in all countries and a decrease in technical charges in Belgium (the figure for the first quarter of 2018 had been impacted by the January storms), the year-on-year increase was due solely to a rise in earned premiums. Consequently, the combined ratio for the first six months of 2018 came to an excellent 88%, in line with the figure recorded for full-year 2017.
Technical insurance income from our life insurance activities stood at 0 million euros, compared to -7 million euros in the previous quarter and -25 million in the year-earlier quarter. Sales of life insurance products (426 million euros) were 14% lower than in the previous quarter (drop mainly in unit-linked products) and were up 3% on the year-earlier quarter (drop in sales of unit-linked products offset by increased sales of guaranteed-interest products). Overall, the share of guaranteed-interest products in total life insurance sales stood at 61% in the second quarter of 2018, with unit-linked products accounting for the remaining 39%.
At 438 million euros, net fee and commission income remained robust, though on a comparable basis, it was down 3% and 4%, respectively, on its level of the previous and year-earlier quarters. Essentially, this was caused in both cases by the lower level of entry fees generated by our asset management activities (due to the more uncertain investment climate in the quarter under review) and lower securities-related fees. This was partly offset by higher payment services-related fees and (year-on-year) the beneficial effect of the inclusion of UBB/Interlease. At the end of June 2018, our total assets under management stood at 214 billion euros, more or less stable quarter-on-quarter and up 1% year-on-year (positive price performance).
All other remaining income items amounted to an aggregate 119 million euros, compared to 189 million euros in the previous quarter and 265 million euros in the year-earlier quarter (on a comparable basis). The figure for the second quarter of 2018 included relatively high dividend income of 34 million euros (the second quarter of the year traditionally includes the bulk of received dividends) and net realised result from debt instruments at fair value of 8 million euros. It also included 23 million euros in other net income, down on the previous quarter on account of a negative one-off item related to the settlement of a legacy legal case (-38 million euros), whereas the previous quarter had benefited from certain positive one-off items, viz. the settlement of another old legal case and the sale of a building (an aggregate 25 million euros). The other remaining income items also included the 54-million-euro net result from financial instruments at fair value (trading and fair value income). This figure was down significantly on both reference quarters, due to the combination of a lower value of derivatives used for asset/liability management purposes, the negative impact of various valuation adjustments and lower dealing room income in the Czech Republic, partly offset by higher realised gains on the sale of shares in the insurance portfolio.
| Operating expenses | The comparison of expenses is distorted by the traditional upfront recognition in the first quarter of the year of the bulk of bank taxes for the full year. Excluding these taxes, |
|---|---|
| 966 million euros |
expenses in the second quarter were up 2% on the previous quarter. |
Operating expenses in the second quarter of 2018 stood at 966 million euros. The quarter-on-quarter comparison is distorted by the traditional upfront recognition in the first quarter of most of the bank taxes for the full year (371 million euros in the first quarter of 2018, compared to only 24 million euros in the second quarter of 2018). Excluding bank taxes, costs increased by 2% quarteron-quarter, caused largely by increased staff expenses (mainly in Belgium and the Czech Republic), and seasonally higher marketing expenses, ICT costs and professional fees. Costs excluding bank taxes rose 6% year-on-year, partly due to the inclusion of UBB/Interlease, with the rest of the increase being accounted for by inter alia higher ICT costs (investments in digital transformation) and marketing expenses.
As a result, the cost/income ratio of our banking activities stood at 62% in the first six months of the year. When the bank taxes are spread evenly throughout the year and certain non-operational items are excluded, the cost/income ratio came to 56%, roughly in line with the 55% recorded for full-year 2017.
Loan loss impairments Another net release of loan loss impairments thanks to Ireland. Very favourable credit cost ratio of -0.10%.
In the second quarter of 2018, we recorded a 21-million-euro net release of loan loss impairments. This compares with a net release of 63 million euros in the previous quarter and 78 million euros in the second quarter of 2017. As was the case in the past few quarters, the net release of loan loss impairments in the second quarter of 2018 was largely attributable to Ireland (39 million euros in the second quarter of 2018), which came about mainly because of the positive effect of increased house prices on the mortgage loan portfolio. This was partly offset by 26 million euros of additional loan loss impairment charges being recorded in Belgium (related to corporate files). In all the other core countries, there was either a small release of loan loss impairments (Czech Republic, Hungary, Bulgaria and the Group Centre) or a generally low level of loan loss impairment charges (Slovakia). Consequently, the credit cost ratio for the entire group amounted to a very favourable -0.10% for the first six months of the year (a negative figure indicates a net release and, hence, has a positive impact on the results), compared to -0.06% in full-year 2017. Excluding Ireland, the credit cost ratio would have come to 0.00% in the first six months of the year (0.09% in full-year 2017).
The impaired loans ratio improved further in all business units. At the end of June 2018, some 5.5% of our total loan book was classified as impaired, compared with 6.0% at year-end 2017. Impaired credits that are more than 90 days past due amounted to 3.2% of the loan book (3.4% at year-end 2017).
The quarter under review also included 20 million euros in impairment on assets other than loans (partly related to the impact of the review of residual values of financial car leases under short-term contracts in the Czech Republic and to a legacy property file in Bulgaria).
| Net result | Belgium | Czech Republic | International Markets | Group Centre |
|---|---|---|---|---|
| by business unit | 437 million euros | 145 million euros | 163 million euros | -53 million euros |
Belgium: the net result was up 80% quarter-on-quarter, but this was distorted by the upfront booking in the first quarter of 2018 of most of the bank tax for the full year. Excluding bank taxes, the net result was fully in line with the previous quarter, and included a good level of net interest income, a decrease in net fee and commission income (more uncertain investment climate), higher technical insurance income (thanks to a strong performance in the non-life segment), higher trading and fair value income, seasonally higher dividend income and lower net other income (a positive one-off item in the previous quarter). Costs – excluding bank taxes – rose somewhat (mainly staff, ICT and marketing expenses) and loan loss impairment charges remained at a low level.
Czech Republic: disregarding the exchange rate effect, the net result was down 14% on its level for the previous quarter. Excluding bank taxes, the net result fell 24%, due mainly to lower trading and fair value income, and, to a lesser extent, higher costs (mainly staff and marketing expenses).
International Markets: the 163-million-euro net result breaks down as follows: 19 million euros for Slovakia, 62 million euros for Hungary, 26 million euros for Bulgaria and 55 million euros for Ireland. For the business unit as a whole and excluding the impact of the bank tax, the net result was down 6% quarter-on-quarter, due to the fact that the increase in total income (up 13 million euros in total, various income lines) was more than offset by a lower level of net loan loss releases (39 million euros, compared to 61 million euros in the previous quarter).
Group Centre: the net result was down 58 million euros on the level recorded in the previous quarter, due mainly to a negative one-off impact related to the settlement of a legacy legal case (38 million euros), a negative change in the value of derivatives used for asset/liability management purposes and lower releases of loan loss impairments (4 million euros, compared to 16 million euros in the previous quarter).
| Belgium | Czech Republic | International Markets | |||||
|---|---|---|---|---|---|---|---|
| Selected ratios by business unit | 1H2018 | FY2017 | 1H2018 | FY2017 | 1H2018 | FY2017 | |
| Cost/income ratio, banking excluding certain non-operating items and spreading the bank tax evenly throughout the year |
57% | 53% | 45% | 43% | 62% | 72% | |
| Combined ratio, non-life insurance | 87% | 86% | 96% | 97% | 88% | 93% | |
| Credit cost ratio1 | 0.08% | 0.09% | -0.03% | 0.02% | -0.71% | -0.74% | |
| Impaired loans ratio2 | 2.4% | 2.8% | 2.1% | 2.4% | 19.5% | 19.7% |
1 A negative figure indicates a net impairment release (with a positive impact on the results). See 'Details of ratios and terms' in the quarterly report. 2 2018 figures based on a slightly changed definition of the loan portfolio. See 'Credit risk' in the quarterly report.
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
| Equity, solvency, | Total | Common equity | Liquidity coverage | Net stable funding |
|---|---|---|---|---|
| equity | ratio (fully loaded) | ratio | ratio | |
| liquidity | 19.0 billion euros | 15.8% | 139% | 136% |
At the end of June 2018, total equity stood at 19.0 billion euros (16.6 billion euros in parent shareholders' equity and 2.4 billion euros in additional tier-1 instruments), up 1.0 billion euros on its level at the beginning of the year on a like-for-like basis (i.e. after adjustment for the impact of the first-time application of IFRS 9, which led to a drop of 0.7 billion euros). The 'like-for-like' increase of 1.0 billion euros during the first six months of the year resulted from the inclusion of the profit for that period (+1.2 billion euros), the issuance of a new additional tier-1 instrument in April (+1 billion euros), payment of the final dividend for 2017 in May 2018 (-0.8 billion euros), the share buyback (-0.2 billion euros), changes in various revaluation reserves (an aggregate -0.3 billion euros) and a number of minor items. We have provided details of the changes in the 'Consolidated financial statements' section of the quarterly report (under 'Consolidated statement of changes in equity').
At 30 June 2018, our fully loaded common equity ratio (Basel III, under the Danish compromise) stood at a strong 15.8%, compared to 15.9% three months earlier. Note that this ratio includes the effect of the recent share buyback (-0.2%). Our leverage ratio (Basel III, fully loaded) came to 6.0%. The solvency ratio for KBC Insurance under the Solvency II framework was a sound 219% at 30 June 2018. Our liquidity position remained excellent too, as reflected in an LCR ratio of 139% and an NSFR ratio of 136% at the end of June 2018.
| Net result | The net result for the first six months of 2018 was down 16% compared to same period |
|---|---|
| of 2017. On a comparable basis, the increase in net interest income, dividend income | |
| and technical insurance income was more than offset by the significant drop in trading | |
| 1 248 million euros |
and fair value income, lower net fee and commission income and other net income, and |
| higher expenses. The first half results for both 2018 and 2017 benefited from net loan | |
| loss impairment releases, mainly in KBC Bank Ireland. |
Highlights (compared to the first half of 2017, on a comparable basis):
Risk statement: as we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. Although we closely monitor and manage each of these risks within a strict risk framework containing governance and limits, they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of items are considered to constitute the main challenges for the financial sector. Regulatory uncertainty remains a dominant theme for the sector (even though the 'Basel IV' agreement in December has brought some clarification as regards future capital requirements), as does enhanced consumer protection. Another ongoing challenge remains the low interest rate environment, combined with the increased risk of asset bubbles. The financial sector also faces the potential systemic consequences of political and financial developments like Brexit or protectionist measures in the US, which will have an impact on the European economy. Technology used in the financial industry is an additional challenge for the business model of traditional financial institutions. Finally, cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole.
We provide risk management data in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.
Our view on interest rates and foreign exchange rates: In line with its recent communication, we expect the ECB to taper its Asset Purchase Programmes after September 2018 and to end it in December 2018. The first step towards policy rate normalisation will only be taken well after the end of QE (quantitative easing), which is likely to be in the second half of 2019 at the earliest. In the meantime, we expect the Fed to carry out two more rate hikes in 2018 each time by 25 basis points. Consequently, we believe that the US dollar strength against the euro will continue in the short term, as it will benefit from short-term interest rate support arising from the persistent monetary policy divergence. Towards the end of 2018, however, the euro will probably start appreciating again. Given the low-inflation environment and still highly accommodating monetary policy of the ECB, German long-term bond yields are expected to rise only modestly in the period ahead. Unlike the dovish stance of the ECB, the Czech National Bank has been tightening its monetary policy during the past few months and is expected to continue doing so in 2018 given the buoyant Czech growth and inflation environment. We forecast one more rate hike for this year in the Czech Republic, which would bring the repo rate to 1.50% by the end of 2018. As a result, we expect the Czech currency to appreciate moderately to 25.50 Czech koruna per euro by the end of 2018.
Our view on economic growth: the European economic environment remains attractive. Although growth has slowed down somewhat compared to 2017, it remains above trend. Growth has probably already peaked, but we are still optimistic about the years to come. Persistently decreasing unemployment rates, with even growing labour shortages in some European economies, combined with gradually rising wage inflation will continue to support private consumption. Moreover, also investments will remain an important growth driver. The main element that could impede European economic sentiment and growth remains the risk of further economic de-globalisation, including an escalation of trade conflicts.
| Guidance for the remainder of 2018 |
• | In line with our dividend policy, we will pay an interim dividend of 1 euro per share in November (payment date: 16 November 2018; record date: 15 November 2018; ex coupon date: 14 November 2018). |
|---|---|---|
| • | For the rest of 2018, we expect solid returns for all business units. | |
| • | For Ireland, our guidance for loan impairment for full-year 2018 is for a net release of 100 to 150 million euros. |
|
| • | For Belgium, we expect a recurring positive impact on our results from the recent reform of the Belgian income tax system. The negative upfront effect recorded in the last quarter of 2017 should be fully recouped in roughly three years' time. |
Important non-adjusting post-balance sheet event: on 8 August 2018, KBC Bank Ireland reached an agreement with Goldman Sachs to sell part (approximately 1.9 billion euros) of its legacy portfolio, comprising of non-performing corporate loans, nonperforming Irish buy-to-let mortgage loans, and performing & non-performing UK buy-to-let mortgage loans. As a result of the transaction, KBC Bank Ireland's impaired loans ratio reduces by roughly 11 percentage points to around 25% pro forma at end 2Q2018. The transaction is expected to result in a net profit impact of +14 million euros (based on 1Q2018 numbers and including all costs related to the transaction), a release of risk-weighted assets of approximately 0.4 billion euros at KBC Group, leading to an improvement of the KBC Group common equity ratio of 7 bps. The transaction is expected to close in the 4th quarter of 2018.
| Pro forma recalculation of 2017 reference figures for the main income lines, KBC Group (in millions of EUR, unaudited figures) |
Pro forma recalculation of 2017 reference figures | ||||||
|---|---|---|---|---|---|---|---|
| 2Q2018 | 1Q2018 | 4Q2017 | 3Q2017 | 2Q2017 | 1Q2017 | ||
| Net interest income | 1 117 | 1 125 | 1 029 | 1 039 | 1 028 | 1 025 | |
| + interest accruals on FX derivatives | +108 | +75 | +66 | +56 | |||
| = pro forma reference figure (used in our results analysis) | =1 137 | =1 114 | =1 094 | =1 081 | |||
| Net result from financial instruments at fair value through P&L (FIFV) | 54 | 96 | 235 | 182 | 249 | 191 | |
| - interest accruals on FX derivatives | -108 | -75 | -66 | -56 | |||
| - network income | -26 | -25 | -24 | -24 | |||
| + result on equity instruments ('overlay approach') | +17 | +12 | +21 | +19 | |||
| = pro forma reference figure (used in our results analysis) | =118 | =94 | =180 | =130 | |||
| Net fee and commission income | 438 | 450 | 430 | 408 | 430 | 439 | |
| + network income | +26 | +25 | +24 | +24 | |||
| = pro forma reference figure (used in our results analysis) | =456 | =433 | =454 | =463 |
Interest accruals on FX derivatives: moved from FIFV to 'net interest income' (in line with the transition to IFRS 9).
Network income (income received from margins earned on FX transactions carried out by the network for clients): moved from FIFV to 'net fee and commission income'.
Result on equity instruments: in line with the IFRS 9 'overlay approach', realised gains and losses and impairment on what used to be available-for-sale shares in the insurance portfolio have been moved from 'net result from available-for-sales assets' and 'impairment on available-for-sale assets' to FIFV. Please note that, under IFRS 9, realised and unrealised gains/losses on what used to be available-for-sale shares in the banking portfolio are recorded in other comprehensive income (i.e. eliminated from the net result).
2Q 2018 and 6M 2018
Section reviewed by the Auditor
AC: amortised cost AFS: Available For Sale (IAS 39) ALM: Asset Liability Management ECL: Expected Credit Loss FA: Financial Assets FTA: First Time Application/Adoption FV: Fair Value FVA: Funding Value Adjustment FVOCI: Fair Value through Other Comprehensive Income FVPL: Fair Value through Profit or Loss FVPL – overlay: Fair Value through Profit or Loss - overlay GCA: Gross Carrying Amount HFT: Held For Trading HTM: Held To Maturity (IAS 39) OCI: Other Comprehensive Income POCI: Purchased or Originated Credit Impaired Assets SPPI: Solely payments of principal and interest SRB: Single Resolution Board R/E: Retained Earnings
| 1H 2018 | 1H 2017 | 2Q 2018 | 1Q 2018 | 2Q 2017 | ||
|---|---|---|---|---|---|---|
| (in millions of EUR) | e Note | IFRS 9 | IAS 39 | IFRS 9 | IFRS 9 | IAS 39 |
| Net interest income | 3.1 | 2 242 | 2 052 | 1 117 | 1 125 | 1 028 |
| Interest income | 3.1 | 3 394 | 3 142 | 1 712 | 1 682 | 1 566 |
| Interest expense | 3.1 | - 1 153 | - 1 090 | - 595 | - 557 | - 538 |
| Non-life insurance before reinsurance | 3.7 | 364 | 366 | 202 | 162 | 179 |
| Earned premiums Non-life | 3.7 | 770 | 729 | 392 | 378 | 369 |
| Technical charges Non-life | 3.7 | - 406 | - 363 | - 190 | - 216 | - 190 |
| Life insurance before reinsurance | 3.7 | - 5 | - 52 | 1 | - 7 | - 24 |
| Earned premiums Life | 3.7 | 651 | 579 | 315 | 336 | 267 |
| Technical charges Life | 3.7 | - 656 | - 631 | - 314 | - 343 | - 291 |
| Ceded reinsurance result | 3.7 | - 23 | - 13 | - 14 | - 9 | - 10 |
| Dividend income | 3.2 | 55 | 44 | 34 | 21 | 30 |
| Net result from financial instruments at fair value through profit or loss | 3.3 | 150 | 439 | 54 | 96 | 249 |
| Of which Result on equity instruments (overlay) | 52 | - | 33 | 19 | - | |
| Net realised result from available-for-sale assets | - | 97 | - | - | 52 | |
| Net realised result from debt instruments at fair value through OCI | 9 | - | 8 | 1 | - | |
| Net fee and commission income | 3.5 | 889 | 869 | 438 | 450 | 430 |
| Fee and commission income | 3.5 | 1 247 | 1 368 | 600 | 648 | 748 |
| Fee and commission expense | 3.5 | - 359 | - 499 | - 161 | - 197 | - 318 |
| Net other income | 3.6 | 94 | 124 | 23 | 71 | 47 |
| TOTAL INCOME | 3 775 | 3 926 | 1 863 | 1 912 | 1 980 | |
| Operating expenses | 3.8 | - 2 257 | - 2 139 | - 966 | - 1 291 | - 910 |
| Staff expenses | 3.8 | - 1 170 | - 1 141 | - 587 | - 583 | - 577 |
| General administrative expenses | 3.8 | - 951 | - 869 | - 311 | - 640 | - 269 |
| Depreciation and amortisation of fixed assets | 3.8 | - 137 | - 129 | - 69 | - 68 | - 65 |
| Impairment | 3.10 | 58 | 64 | 1 | 56 | 71 |
| On loans and receivables | 3.10 | - | 72 | - | - | 78 |
| On financial assets at amortised cost and at FV through OCI | 3.10 | 84 | - | 21 | 63 | - |
| On available-for-sale assets | 3.10 | - | - 3 | - | - | - 2 |
| On financial assets at fair value through other comprehensive income | 3.10 | 2 | - | 0 | - | |
| On goodwill | 3.10 | 0 | 0 | 0 | 0 | 0 |
| On other | 3.10 | - 26 | - 5 | - 20 | - 6 | - 5 |
| Share in results of associated companies and joint ventures | 3.11 | 10 | 8 | 3 | 6 | 3 |
| RESULT BEFORE TAX | 1 585 | 1 858 | 901 | 683 | 1 144 | |
| Income tax expense | - 337 | - 373 | - 210 | - 127 | - 288 | |
| RESULT AFTER TAX | 1 248 | 1 485 | 692 | 556 | 855 | |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | |
| Attributable to equity holders of the parent | 1 248 | 1 485 | 692 | 556 | 855 | |
| Earnings per share (in EUR) | ||||||
| Basic | 3.13 | 2,91 | 3,49 | 1,61 | 1,30 | 2,01 |
| Diluted | 3.13 | 2,91 | 3,49 | 1,61 | 1,30 | 2,01 |
As of 2018, the financial information is prepared in accordance with IFRS 9.
For more information see 'Statement of compliance and (changes in) accounting policies' (note 1.1) further in this report, including transition disclosures. KBC has opted to use transition relief for disclosing comparative information.
The equity instruments of the insurance companies within the Group are designated under the overlay approach. These equity instruments, mainly classified as AFS under IAS 39, would have been measured at fair value through P&L under IFRS 9. The overlay approach reclassifies from the income statement to OCI the extra volatility related to the adoption of IFRS 9 as long as IFRS 17 is not in place, until 1st January 2021.
The extra volatility due to IFRS 9, and reclassified out of the net result from financial instruments at fair value through profit or loss to the revaluation reserves of equity instruments (overlay approach) refers to the unrealised fair value fluctuations amounting to -75 million euros in 1H 2018. It can be summarized as the difference between
For more information see note 'Summary of significant accounting policies' (note 1.2) further in this report.
| 1H 2018 | 1H 2017 | 2Q 2018 | 1Q 2018 | 2Q 2017 | |
|---|---|---|---|---|---|
| (in millions of EUR) | IFRS 9 | IAS 39 | IFRS 9 | IFRS 9 | IAS 39 |
| RESULT AFTER TAX | 1 248 | 1 485 | 692 | 556 | 855 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 1 248 | 1 485 | 692 | 556 | 855 |
| Other comprehensive income - to be recycled to P&L | - 241 | - 22 | - 167 | - 75 | 84 |
| Net change in revaluation reserve AFS equity | - | - 5 | - | - | - 42 |
| Net change in revaluation reserve AFS bonds | - | - 169 | - | - | 45 |
| Net change in revaluation reserve FVOCI debt instruments | - 138 | - | - 105 | - 33 | - |
| Net change in revaluation reserve (AFS assets) - Other | - | 0 | - | - | 0 |
| Net change in revaluation reserve FVPL equity instruments - overlay approach | - 75 | - | 12 | - 88 | - |
| Net change in hedging reserve - cash flow hedge | 17 | 160 | - 31 | 48 | 80 |
| Net change in translation differences | - 136 | - 5 | - 136 | 0 | - 3 |
| Hedge of net investments in foreign operations | 97 | 0 | 98 | - 1 | 0 |
| Net change related to associated companies & joint ventures | - 7 | - 2 | - 6 | 0 | 5 |
| Other movements | 0 | - 1 | 0 | - 1 | - 1 |
| Other comprehensive income - not to be recycled to P&L | - 12 | 27 | - 12 | 0 | - 11 |
| Net change in revaluation reserve FVOCI equity instruments | 5 | - | 2 | 3 | - |
| Net change in defined benefit plans | - 19 | 33 | - 16 | - 3 | - 8 |
| Net change on own credit risk - liabilities designated at FVPL | 3 | - 5 | 3 | 0 | - 3 |
| Net change related to associated companies & joint ventures | 0 | 0 | 0 | 0 | 0 |
| TOTAL COMPREHENSIVE INCOME | 995 | 1 490 | 513 | 482 | 928 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 994 | 1 490 | 513 | 482 | 928 |
As of 2018, the financial information is prepared in accordance with IFRS 9.
The largest movements in other comprehensive income (1H 2018 vs. 1H 2017):
| 30-06-2018 | 31-12-2017 | 01-01-2018 | ||
|---|---|---|---|---|
| ASSETS (in millions of EUR) | Note | IFRS 9 | IAS 39 | IFRS9 |
| Cash, cash balances at central banks and other demand deposits from credit institutions | - | 31 346 | 29 727 | |
| Financial assets | 4.0 | 262 170 | 254 753 | 253 817 |
| Held for trading | 4.0 | - | 7 431 | - |
| Designated at fair value through profit or loss | 4.0 | - | 14 484 | - |
| Available for sale | 4.0 | - | 34 156 | - |
| Loans and receivables | 4.0 | - | 167 458 | - |
| Held to maturity | 4.0 | - | 30 979 | - |
| Amortised cost | 4.0 | 220 105 | - | 210 865 |
| Fair value through OCI | 4.0 | 18 451 | - | 19 516 |
| Fair value through profit or loss | 4.0 | 23 359 | - | 23 191 |
| Of which held for trading | 4.0 | 7 580 | - | 7 148 |
| Hedging derivatives | 4.0 | 255 | 245 | 245 |
| Reinsurers' share in technical provisions | 5.6 | 131 | 131 | |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk | - | - 18 | - 78 | |
| Tax assets | 5.2 | 1 739 | 1 625 | |
| Current tax assets | 5.2 | 189 | 82 | |
| Deferred tax assets | 5.2 | 1 550 | 1 543 | |
| Non-current assets held for sale and assets associated with disposal groups | 46 - | 13 | 21 | |
| Investments in associated companies and joint ventures | 5.4 | 201 | 240 | |
| Property, equipment and investment property | 3 314 | 3 207 | ||
| Goodwill and other intangible assets | 5.5 | 1 228 | 1 205 | |
| Other assets | 5.1 | 1 808 | 1 512 | |
| TOTAL ASSETS | 301 934 | 292 342 | ||
| LIABILITIES AND EQUITY (in millions of EUR) | Note | 30-06-2018 | 31-12-2017 | 01-01-2018 |
| Financial liabilities | 4.0 | 260 962 | 251 260 | 251 260 |
| Amortised cost | 4.0 | 238 772 | 227 944 | |
| Fair value through profit or loss | 4.0 | 21 028 | 22 032 | |
| Of which held for trading | 4.0 | 6 057 | 6 998 | |
| Hedging derivatives | 4.0 | 1 161 | 1 284 | |
| Technical provisions, before reinsurance | 5.6 | 18 595 | 18 641 | |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk | - | - 127 | - 86 | |
| Tax liabilities | 5.2 | 409 | 582 | |
| Current tax liabilities | 5.3 | 94 | 148 | |
| Deferred tax liabilies | 5.4 | 315 | 434 | |
| Liabilities associated with disposal groups | 46 46 |
0 | 0 | |
| Provisions for risks and charges | 5.7 | 312 | 399 | |
| Other liabilities | 5.8 | 2 767 | 2 743 | |
| TOTAL LIABILITIES | 282 918 | 273 540 | ||
| Total equity | 5.10 | 19 016 | 18 803 | |
| Parent shareholders' equity | 5.10 | 16 616 | 17 403 | 16 657 |
| Additional Tier-1 instruments included in equity | 5.10 | 2 400 | 1 400 | |
| Minority interests TOTAL LIABILITIES AND EQUITY |
- | 0 301 934 |
0 292 342 |
| 30-06-2018 | Additional Tier-1 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Issued and | Total | instruments | |||||||
| paid up share | Share | Treasury | Retained | revaluation | Parent share | included in | Minority | ||
| In millions of EUR | capital | premium | shares | earnings | reserves | holders' equity | equity | interests | Total equity |
| 1H 2018 IFRS 9 | |||||||||
| Balance at the end of the period (31-12-2017) | 1 456 | 5 467 | - 5 | 10 101 | 383 | 17 403 | 1 400 | 0 | 18 803 |
| Impact transition to IFRS 9 | 0 | 0 | 0 | - 247 | - 499 | - 746 | 0 | 0 | - 746 |
| Balance at the beginning of the period (01-01-2018) after impact IFRS 9 | 1 456 | 5 467 | - 5 | 9 854 | - 116 | 16 657 | 1 400 | 0 | 18 057 |
| Net result for the period | 0 | 0 | 0 | 1 248 | 0 | 1 248 | 0 | 0 | 1 248 |
| Other comprehensive income for the period | 0 | 0 | 0 | 0 | - 253 | - 253 | 0 | 0 | - 253 |
| Subtotal | 0 | 0 | 0 | 1 247 | - 253 | 994 | 0 | 0 | 995 |
| Dividends | 0 | 0 | 0 | - 838 | 0 | - 838 | 0 | 0 | - 838 |
| Coupon additional Tier-1 instruments | 0 | 0 | 0 | - 28 | 0 | - 28 | 0 | 0 | - 28 |
| Transfer from reserve to retained earnings on realisations | 0 | 0 | 0 | - 7 | 0 | - 7 | 0 | 0 | - 7 |
| Issue of additional Tier-1 instruments included in equity | 0 | 0 | 0 | - 5 | 0 | - 5 | 1 000 | 0 | 995 |
| Purchases/sales of treasury shares | 0 | 0 | - 159 | 0 | 0 | - 159 | 0 | 0 | - 159 |
| Total change | 0 | 0 | - 159 | 371 | - 253 | - 41 | 1 000 | 0 | 959 |
| Balance at the end of the period | 1 456 | 5 467 | - 163 | 10 225 | - 369 | 16 616 | 2 400 | 0 | 19 016 |
| of which relating to equity method | 20 | 20 | 20 | ||||||
| Revaluation reserve |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revaluation | FVPL equity | Revaluation | Hedging | Hedge of net | ||||||
| Revaluation | reserve | instruments - | reserve | reserve - | investments | Remeasurement | Total | |||
| reserve | FVOCI debt | overlay | FVOCI equity | cashflow | Translation | in foreign | of defined benefit | Own credit risk | revaluation | |
| In millions of EUR | AFS assets | instruments | approach | instruments | hedges | differences | operations | obligations | (through OCI) | reserves |
| 1H 2018 IFRS 9 | ||||||||||
| Balance at the end of the period (31-12-2017) | 1 751 | 0 | 0 | 0 | -1 339 | - 11 | 45 | - 52 | - 10 | 383 |
| Impact transition to IFRS 9 | -1 751 | 837 | 387 | 29 | 0 | 0 | 0 | - 499 | ||
| Balance at the beginning of the period (01-01-2018) after impact IFRS 9 | 0 | 837 | 387 | 29 | -1 339 | - 11 | 45 | - 52 | - 10 | - 116 |
| Net result for the period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other comprehensive income for the period | 0 | - 141 | - 75 | 4 | 17 | - 140 | 97 | - 19 | 3 | - 253 |
| Subtotal | 0 | - 141 | - 75 | 4 | 17 | - 140 | 97 | - 19 | 3 | - 253 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coupon additional Tier-1 instruments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Transfer from reserve to retained earnings on realisations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Issue of additional Tier-1 instruments included in equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases/sales of treasury shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total change | 0 | - 141 | - 75 | 4 | 17 | - 140 | 97 | - 19 | 3 | - 253 |
| Balance at the end of the period | 0 | 696 | 312 | 33 | -1 321 | - 151 | 142 | - 71 | - 8 | - 369 |
| of which relating to equity method | 0 | 7 | 0 | 1 | 0 | 12 | 0 | 0 | 0 | 20 |
| 30-06-2017 | Issued and | Revaluation | Hedging reserve |
Remeasurement | Own credit risk |
Total | Parent share |
Additional Tier-1 instruments |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| paid up share capital |
Share premium |
Treasury shares |
Retained earnings |
reserve (AFS assets) |
(cashflow hedges) |
Translation differences |
of defined benefit obligations |
(through OCI) |
revaluation reserves |
holders' equity |
included in equity |
Minority interests |
Total equity | |
| 1H 2017 IAS 39 | ||||||||||||||
| Balance at the end of the period (31-12-2016) | 1 455 | 5 453 | 0 | 8 751 | 1 756 | -1 347 | 31 | - 138 | - 4 | 298 | 15 957 | 1 400 | 0 | 17 357 |
| Net result for the period | 0 | 0 | 0 | 1 485 | 0 | 0 | 0 | 0 | 0 | 0 | 1 485 | 0 | 0 | 1 485 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 1 | - 181 | 160 | - 1 | 33 | - 5 | 6 | 5 | 0 | 0 | 5 |
| Subtotal | 0 | 0 | 0 | 1 484 | - 181 | 160 | - 1 | 33 | - 5 | 6 | 1 490 | 0 | 0 | 1 490 |
| Dividends | 0 | 0 | 0 | - 753 | 0 | 0 | 0 | 0 | 0 | 0 | - 753 | 0 | 0 | - 753 |
| Coupon additional Tier-1 instruments | 0 | 0 | 0 | - 26 | 0 | 0 | 0 | 0 | 0 | 0 | - 26 | 0 | 0 | - 26 |
| Purchases of treasury shares | 0 | 0 | - 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 2 | 0 | 0 | - 2 |
| Total change | 0 | 0 | - 2 | 705 | - 181 | 160 | - 1 | 33 | - 5 | 6 | 708 | 0 | 0 | 708 |
| Balance at the end of the period | 1 455 | 5 453 | - 2 | 9 456 | 1 575 | -1 187 | 30 | - 105 | - 10 | 303 | 16 665 | 1 400 | 0 | 18 065 |
| of which revaluation reserve for shares of which revaluation reserve for bonds |
485 1 090 |
|||||||||||||
| of which relating to equity method | 19 | 0 | 11 | 0 | 0 | 30 | 30 | 30 |
Dividend over 2017: in line with our dividend policy, KBC paid an interim dividend of 1 euro per share (418 million euros in total), as an advance payment on the total dividend (deducted from retained earnings in 2017).
Furthermore, for 2017 the board of directors has additionally proposed to the general meeting of shareholders, which was approved on 3 May 2018, a closing dividend of 2 euro per share (a total of 837 million euros is deducted from retained earnings in 2Q 2018).
Also a buy-back of 2.7 million shares (roughly 0.2bn EUR) was proposed to the Annual Meeting which was approved on 3 May 2018 (i.e. a pay-out ratio of 59% including the total dividend, AT1 coupon and share buy-back).
Based on value date end of June, 2 380 929 shares have been bought back for a total amount of 160 million euros under the share buyback program. Until 03-07-2018 a total number of 2.700.000 of own shares were bought for a total amount of 181 million euros.
For more information see note 'Parent shareholders equity and AT1 instruments' (note 5.10) further in this report.
| 1H 2018 | 1H 2017 | |
|---|---|---|
| In millions of EUR | IFRS 9 | IAS 39 |
| Cash and cash equivalents at the beginning of the period | 40 413 | 26 747 |
| Net cash from (used in) operating activities | 2 885 | 13 451 |
| Net cash from (used in) investing activities | 2 314 | 2 490 |
| Net cash from (used in) financing activities | 578 | - 337 |
| Effects of exchange rate changes on opening cash and cash equivalents | - 400 | 330 |
| Cash and cash equivalents at the end of the period | 45 791 | 42 681 |
The positive net cash from operating activities in 1H 2018 is mainly thanks to the realized result and lower outstanding debt securities at fair value through OCI (versus year-end 2017). The positive net cash from operating activities in 1H 2017 is largely thanks to higher deposits (versus year-end 2016).
The net cash flow from financing activities in 1H 2018 includes:
The condensed interim financial statements of the KBC Group for the second quarter 2018 and first half 2018 have been prepared in accordance with IAS 34, 'Interim financial reporting'. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2017, which have been prepared in accordance with the International Financial Reporting Standards as adopted for use in the European Union ('endorsed IFRS').
The following IFRS standards became effective on 1 January 2018 and have been applied in this report:
other triggers indicate otherwise. For 'Stage 1' and 'Stage 2' – under IAS 39 – KBC recorded incurred-but-notreported (IBNR) impairment losses, which are influenced by emergence periods. Under IFRS 9, impairment of financial assets is calculated on a 12-month expected credit loss (ECL) basis for 'Stage 1' and on a lifetime ECL basis for 'Stage 2'. Forward looking information is incorporated into the staging criteria and measurement of ECL. Different macroeconomic factors are taken into consideration and KBC applies three scenarios to evaluate a range of possible outcomes.
The following other change in presentation and accounting policies is applied in 2018:
o A change in presentation was made with regard to 'Network income' which is shifted from 'Net result from financial instruments at fair value through profit or loss' to 'Net fee and commission income'. 'Network income' is income received from margins earned on FX transactions (related to payments, credits, deposits, investments) and performed by the network (branches, online) for clients. The new presentation better reflects the business reality it concerns income received from margins earned on FX transactions carried out by the network for clients. The financial statements have not been restated retroactively according to IAS 8, as the total impact on them is considered to be non-material (a one-off impact of 25 million euros in 1Q 2018 and 24 million euros in 2Q 2018, before tax).
The following IFRS standards were issued but not yet effective in 2018. KBC will apply these standards when they become mandatory.
• IFRS 16
relevant accounting aspects. The core of IFRS 17 is the general model, supplemented by a specific adaptation for contracts with direct participation features (the variable fee approach) and a simplified approach (the premium allocation approach) mainly for short-duration contracts. IFRS 17 will become effective for reporting periods beginning on or after 1 January 2021 (subject to EU endorsement), with comparative figures being required. An impact study is an inherent part of the IFRS 17 project that is currently underway at KBC.
The significant accounting policies were adjusted to take into account IFRS 9 and were re-designed. For an overview of new accounting policies, see the Consolidated financial statements according to IFRS of 1Q 2018 (pages 19 to 34).
As from the 1st of January 2018, the consolidated financial statements are prepared in accordance with IFRS 9. KBC has opted to make use of transition relief for disclosing comparative information.
Total FTA (first time application) impact of the transition from IAS 39 to IFRS 9 as per 1st January 2018, including both the impact on the financial assets and provisions, is a decrease in equity amounting to -949 million euros before tax (-746 million euros after tax), split between:
For more information on transition disclosures see the Consolidated financial statements according to IFRS 1Q 2018 (pages 35 to 37).
Segment reporting according to the management structure of the group (note 2.2 in the annual accounts 2017)
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2017.
| Business | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| unit | |||||||||
| Business | Business | Interna | |||||||
| unit | unit Czech | tional | of which: | of which: | of which: | of which: | Group | KBC | |
| In millions of EUR | Belgium | Republic | Markets | Hungary | Slovakia | Bulgaria | Ireland | Centre | Group |
| 1H 2018 IFRS 9 | |||||||||
| Net interest income | 1 291 | 489 | 449 | 120 | 104 | 76 | 148 | 13 | 2 242 |
| Non-life insurance before reinsurance | 247 | 51 | 57 | 21 | 12 | 25 | 0 | 9 | 364 |
| Earned premiums Non-life | 524 | 119 | 121 | 53 | 19 | 48 | 0 | 7 | 770 |
| Technical charges Non-life | - 277 | - 68 | - 63 | - 33 | - 8 | - 23 | 0 | 2 | - 406 |
| Life insurance before reinsurance | - 49 | 29 | 15 | 5 | 6 | 4 | 0 | 0 | - 5 |
| Earned premiums Life | 485 | 118 | 49 | 8 | 27 | 13 | 0 | - 1 | 651 |
| Technical charges Life | - 534 | - 89 | - 34 | - 4 | - 21 | - 9 | 0 | 0 | - 656 |
| Ceded reinsurance result | - 12 | - 5 | - 7 | 1 | - 23 | ||||
| Dividend income | 50 | 0 | 0 | - 1 | - 1 | - 4 | 0 | 5 | 55 |
| Net result from financial instruments at fair value through profit or loss | 87 | 48 | 42 | 0 | 0 | 0 | 0 | - 27 | 150 |
| Net realised result from debt instruments at fair value through OCI | 0 | 0 | 1 | 33 | 3 | 6 | 0 | 8 | 9 |
| 0 | 0 | 1 | 0 | ||||||
| Net fee and commission income | 620 | 131 | 141 | 97 | 28 | 16 | - 1 | - 3 | 889 |
| Net other income | 108 | 7 | 16 | 14 | 4 | - 1 | 0 | - 37 | 94 |
| TOTAL INCOME | 2 342 | 751 | 714 | 288 | 156 | 122 | 148 | - 32 | 3 775 |
| Operating expenses | - 1 384 | - 362 | - 462 | - 183 | - 102 | - 77 | - 100 | - 50 | - 2 257 |
| Impairment | - 40 | - 16 | 94 | 7 | 0 | 6 | 81 | 20 | 58 |
| On financial assets at amortised cost and at FV through OCI | - 40 | 3 | 100 | 7 | 0 | 12 | 81 | 20 | 84 |
| On goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| On other | 0 | - 19 | - 6 | 0 | 0 | - 6 | - 1 | 0 | - 26 |
| Share in results of associated companies and joint ventures | - 5 | 12 | 3 | 0 | 0 | 1 | 0 | 0 | 10 |
| RESULT BEFORE TAX | 913 | 385 | 349 | 113 | 54 | 52 | 129 | - 62 | 1 585 |
| Income tax expense | - 232 | - 69 | - 50 | - 16 | - 12 | - 5 | - 16 | 14 | - 337 |
| RESULT AFTER TAX | 680 | 316 | 299 | 96 | 42 | 47 | 113 | - 48 | 1 248 |
| Attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NET RESULT | 680 | 316 | 299 | 96 | 42 | 47 | 113 | - 48 | 1 248 |
| 1H 2017 IAS 39 | |||||||||
| Net interest income | 1 236 | 436 | 384 | 118 | 106 | 24 | 135 | - 3 | 2 052 |
| Non-life insurance before reinsurance | 274 | 40 | 48 | 18 | 12 | 18 | 0 | 4 | 366 |
| Earned premiums Non-life | 514 | 101 | 110 | 48 | 17 | 45 | 0 | 4 | 729 |
| Technical charges Non-life | - 240 | - 61 | - 62 | - 30 | - 5 | - 27 | 0 | 0 | - 363 |
| Life insurance before reinsurance | - 87 | 23 | 12 | 3 | 6 | 2 | 0 | 0 | - 52 |
| Earned premiums Life | 440 | 95 | 44 | 8 | 26 | 10 | 0 | 0 | 579 |
| Technical charges Life | - 527 | - 73 | - 32 | - 5 | - 19 | - 8 | 0 | 1 | - 631 |
| Ceded reinsurance result | - 9 | - 4 | - 2 | - 1 | - 1 | 0 | 0 | 1 | - 13 |
| Dividend income | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 44 |
| Net result from financial instruments at fair value through profit or loss | 284 | 115 | 48 | 33 | 9 | 1 | 5 | - 7 | 439 |
| Net realised result from available-for-sale assets | 55 | 17 | 2 | 2 | 0 | 1 | 0 | 23 | 97 |
| Net fee and commission income | 677 | 95 | 102 | 77 | 25 | - 3 | 0 | - 4 | 869 |
| Net other income | 85 | 31 | 5 | 0 | 4 | 1 | 0 | 3 | 124 |
| TOTAL INCOME | 2 550 | 753 | 598 | 251 | 163 | 43 | 139 | 25 | 3 926 |
| Operating expenses | - 1 366 | - 316 | - 395 | - 178 | - 100 | - 29 | - 87 | - 62 | - 2 139 |
| Impairment | - 58 | - 10 | 139 | 9 | - 3 | - 4 | 137 | - 7 | 64 |
| On loans and receivables | - 54 | - 6 | 140 | 10 | - 2 | - 4 | 137 | - 7 | 72 |
| On available-for-sale assets | - 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 3 |
| On goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| On other | - 1 | - 3 | - 1 | 0 | - 5 | ||||
| Share in results of associated companies and joint ventures | - 4 | 10 | 2 | - 1 | 0 | 0 | 0 | 0 | 8 |
| 0 | 0 | 0 | 0 | ||||||
| RESULT BEFORE TAX | 1 121 | 437 | 344 | 82 | 60 | 10 | 189 | - 44 | 1 858 |
| Income tax expense | - 336 | - 73 | - 53 | - 14 | - 14 | - 1 | - 24 | 89 | - 373 |
| RESULT AFTER TAX | 785 | 364 | 292 | 68 | 47 | 9 | 166 | 45 | 1 485 |
| Attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NET RESULT | 785 | 364 | 292 | 68 | 47 | 9 | 166 | 45 | 1 485 |
| In millions of EUR | 1H 2018 | 1H 2017 | 2Q 2018 | 1Q 2018 | 2Q 2017 |
|---|---|---|---|---|---|
| IFRS 9 | IAS 39 | IFRS 9 | IFRS 9 | IAS 39 | |
| Total | 2 242 | 2 052 | 1 117 | 1 125 | 1 028 |
| Interest income | 3 394 | 3 142 | 1 712 | 1 682 | 1 566 |
| Interest income on financial instruments calculated using effective interest rate | |||||
| method | |||||
| Loans and receivables | - | 1 878 | - | - | 957 |
| Held-to-maturity investments | - | 438 | - | - | 203 |
| Financial assets at amortised cost | 2 568 | - | 1 286 | 1 282 | - |
| Available-for-sale assets | - | 327 | - | - | 161 |
| Financial assets at fair value through OCI | 198 | - | 97 | 100 | - |
| Derivatives under hedge accounting | 171 | 127 | 121 | 50 | 59 |
| Other assets not at fair value | 38 | 75 | 19 | 19 | 42 |
| Interest income on other financial instruments | |||||
| Financial assets mandatorily at fair value other than HFT | 4 | 0 | 2 | 2 | 0 |
| Financial assets held for trading | 416 | 295 | 187 | 229 | 143 |
| of which economic hedge | 403 | 284 | 180 | 223 | 137 |
| Other financial assets at fair value through profit or loss | 0 | 3 | 0 | 0 | 1 |
| Interest expense | -1 153 | -1 090 | - 595 | - 557 | - 538 |
| Interest expense on financial instruments calculated using effective interest rate | |||||
| method | |||||
| Financial liabilities measured at amortised cost | - 518 | - 465 | - 263 | - 255 | - 237 |
| Derivatives under hedge accounting | - 266 | - 232 | - 164 | - 103 | - 107 |
| Other | - 60 | - 39 | - 31 | - 30 | - 22 |
| Interest expense on other financial instruments | |||||
| Financial liabilities held for trading | - 292 | - 334 | - 130 | - 161 | - 163 |
| of which economic hedge | - 277 | - 325 | - 124 | - 154 | - 159 |
| Financial liabilities designated at fair value through profit or loss | - 13 | - 16 | - 7 | - 6 | - 8 |
| Net interest expense on defined benefit plans | - 3 | - 4 | - 1 | - 1 | - 2 |
The presentation of interest accruals for FX derivatives has changed: for more information see 'Statement of compliance' (note 1.1).
As of 2018, the financial information is prepared in accordance with IFRS 9. Equity instruments of the insurance companies are accounted for using the overlay approach. For more information see consolidated financial statements according to IFRS 1Q 2018 under 'Summary of significant accounting policies' (note 1.2).
The result from financial instruments at fair value through profit or loss in 2Q 2018 is 41 million euros lower compared to 1Q 2018. The quarter-on-quarter decrease is due to:
Compared to 2Q 2017, the result from financial instruments at fair value through profit or loss is 194 million euros lower in 2Q 2018, for a large part explained by:
o With regard to 'Network income' which is shifted from 'Net result from financial instruments at fair value through profit or loss' to 'Net fee and commission income' for an amount of 24 million euros in 2Q 2017 (for more information, see note 'Statement of compliance' (note 1.1)).
o With regard to overlay approach equity instruments insurance: as of 2018, the result from financial instruments at fair value through profit or loss includes the net realized result and impairments on equity instruments of the insurers (+21 million euros in 2Q 2017).
The result from financial instruments at fair value through profit or loss in 1H 2018 is 289 million euros lower compared to 1H 2017, for a large part explained by:
| In millions of EUR | 1H 2018 | 1H 2017 | 2Q 2018 | 1Q 2018 | 2Q 2017 |
|---|---|---|---|---|---|
| Total | 889 | 869 | 438 | 450 | 430 |
| Income | 1 247 | 1 368 | 600 | 648 | 748 |
| Expense | - 359 | - 499 | - 161 | - 197 | - 318 |
| Breakdown by type | |||||
| Asset Management Services | 580 | 637 | 281 | 299 | 314 |
| Income | 607 | 664 | 295 | 313 | 331 |
| Expense | - 27 | - 28 | - 14 | - 14 | - 18 |
| Banking Services | 439 | 374 | 223 | 215 | 190 |
| Income | 606 | 675 | 288 | 318 | 407 |
| Expense | - 167 | - 301 | - 65 | - 102 | - 217 |
| Distribution | - 130 | - 141 | - 66 | - 64 | - 73 |
| Income | 34 | 29 | 17 | 17 | 10 |
| Expense | - 164 | - 170 | - 83 | - 81 | - 83 |
A change in presentation was made with regard to 'Network income' which is shifted from 'Net result from financial instruments at fair value through profit or loss' to 'Net fee and commission income'. 'Network income' is income received from margins earned on FX transactions (related to payments, credits, deposits, investments) and performed by the network (branches, online) for clients. The new presentation better reflects the business reality, it concerns income received from margins earned on FX transactions carried out by the network for clients. The financial statements have not been restated retroactively according to IAS 8, as the total impact on them is considered to be non-material (a one-off impact of 25 million euros in 1Q 2018 and 24 million euros in 2Q 2018, before tax. For 1H 2018 network income amounts to 49 million euros, before tax).
The substantial higher amounts in 2Q 2017 of the fee and commission income as well as expense within banking services is related to stock lending: the income includes dividends received on borrowed shares, while the expense includes the transfer of this dividend to the lender of the shares. These amounts have been netted in 2018.
As of 2018, the financial information is prepared in accordance with IFRS 9. However, net fee and commission income is not impacted. The impact of the implementation of IFRS 15 (revenue recognition) is negligible.
| Net other income (note 3.6 in the annual accounts | 2017) | ||
|---|---|---|---|
| --------------------------------------------------- | -- | -- | ------- |
| 1H 2018 | 1H 2017 | 2Q 2018 | 1Q 2018 | 2Q 2017 | |
|---|---|---|---|---|---|
| In millions of EUR | IFRS 9 | IAS 39 | IFRS 9 | IFRS 9 | IAS 39 |
| Total | 94 | 124 | 23 | 71 | 47 |
| Of which net realised result following | |||||
| The sale of loans and receivables | - | 2 | - | - | 0 |
| The sale of held-to-maturity investments | - | 2 | - | - | - 4 |
| The sale of financial assets at amortised cost | 11 | - | 11 | 1 | - |
| The repurchase of financial liabilities measured at amortised cost | 0 | 0 | 0 | 0 | 0 |
| Other: of which: | 83 | 120 | 12 | 70 | 51 |
| Income concerning leasing at the KBC Lease-group | 35 | 40 | 17 | 17 | 20 |
| Income from Group VAB | 30 | 36 | 15 | 15 | 18 |
| Settlement of an old legal file | - 20 | 14 | - 38 | 18 | 0 |
Note : settlement of old legal files concerns Group Centre (in 2Q 2018 and 1Q 2018) and Czech Republic (in 1Q 2017 of 14 million euros).
| Breakdown of the insurance results (note 3.7.1 | in the annual accounts 2017) |
|---|---|
| ------------------------------------------------ | --------------------------------- |
| Non | ||||
|---|---|---|---|---|
| technical | ||||
| In millions of EUR | Life | Non-life | account | TOTAL |
| 1H 2018 IFRS 9 | ||||
| Earned premiums, insurance (before reinsurance) | 652 | 780 | 1 432 | |
| Technical charges, insurance (before reinsurance) | - 657 | - 406 | - 1 063 | |
| Net fee and commission income | - 11 | - 151 | - 162 | |
| Ceded reinsurance result | 0 | - 23 | - 23 | |
| Operating expenses | - 82 | - 125 | - 1 | - 209 |
| Internal costs claim paid | - 4 | - 29 | - 33 | |
| Administration costs related to acquisitions | - 17 | - 37 | - 54 | |
| Administration costs | - 61 | - 59 | - 120 | |
| Management costs investments | 0 | 0 | - 1 | - 1 |
| Technical result | - 99 | 75 | - 1 | - 25 |
| Net interest income | 252 | 252 | ||
| Dividend income | 35 | 35 | ||
| Net result from financial instruments at fair value | 62 | 62 | ||
| Net realised result from FVOCI assets | 1 | 1 | ||
| Net other income | 2 | 2 | ||
| Impairments | 1 | 1 | ||
| Allocation to the technical accounts | 287 | 41 | - 328 | 0 |
| Technical-financial result | 188 | 116 | 24 | 330 |
| Share in results of associated companies and joint ventures | 2 | 2 | ||
| RESULT BEFORE TAX | 188 | 116 | 26 | 332 |
| Income tax expense | - 75 | |||
| RESULT AFTER TAX | 257 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 257 | |||
| 1H 2017 IAS 39 | ||||
| Earned premiums, insurance (before reinsurance) | 580 | 740 | 1 320 | |
| Technical charges, insurance (before reinsurance) | - 632 | - 363 | - 995 | |
| Net fee and commission income | - 3 | - 142 | - 145 | |
| Ceded reinsurance result | - 1 | - 13 | - 14 | |
| Operating expenses | - 77 | - 122 | - 1 | - 201 |
| Internal costs claim paid | - 4 | - 28 | - 32 | |
| Administration costs related to acquisitions | - 16 | - 40 | - 55 | |
| Administration costs | - 57 | - 55 | - 112 | |
| Management costs investments | 0 | 0 | - 1 | - 1 |
| Technical result | - 132 | 99 | - 1 | - 35 |
| Net interest income | 284 | 284 | ||
| Dividend income | 27 | 27 | ||
| Net result from financial instruments at fair value | - 6 | - 6 | ||
| Net realised result from AFS assets | 47 | 47 | ||
| Net other income | - 8 | - 8 | ||
| Impairments | - 4 | - 4 | ||
| Allocation to the technical accounts | 276 | 43 | - 319 | 0 |
| Technical-financial result | 143 | 142 | 21 | 306 |
| Share in results of associated companies and joint ventures | 2 | 2 | ||
| RESULT BEFORE TAX | 143 | 142 | 23 | 308 |
| Income tax expense | - 85 | |||
| RESULT AFTER TAX | 223 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 223 |
Note: Figures for premiums exclude the investment contracts without DPF, which roughly coincide with the unit-linked products. Figures are before elimination of transactions between the bank and insurance entities of the group (more information in the 2017 annual accounts).
As of 2018, the financial information is prepared in accordance with IFRS 9. Equity instruments of the insurance companies are accounted for using the overlay approach. For more information see note 'Summary of significant accounting policies' (note 1.2), as well as the narrative under the income statement.
Because of the overlay approach, the bottom line P&L impact of equity instruments will not be different under IAS 39 or IFRS 9. However, under IAS 39 the proceeds of sales were presented in 'Net realised result from available-for-sale assets', and the impairment losses on these equity instruments were included in 'Impairment'. Under IFRS 9 with the overlay approach, these impacts are presented in 'Net result from financial instruments at fair value through profit or loss'.
The technical result non-life was negatively impacted by storms in Belgium in January 2018 for an amount of about -35 million euros (pre-tax; no impact of reinsurance).
As of 2018, the financial information is prepared in accordance with IFRS 9. However, operating expenses are not impacted.
The operating expenses for 2Q 2018 include 24 million euros related to bank (and insurance) levies (371 million euros in 1Q 2018; 19 million euros in 2Q 2017; 395 million euros in 1H 2018 and 380 million euros in 1H 2017). Application of IFRIC 21 (Levies) has as a consequence that certain levies are taken upfront in expense of the first quarter of the year.
| 1H 2018 | 1H 2017 | 2Q 2018 | 1Q 2018 | 2Q 2017 | |
|---|---|---|---|---|---|
| In millions of EUR | IFRS 9 | IAS 39 | IFRS 9 | IFRS 9 | IAS 39 |
| Total | 58 | 64 | 1 | 56 | 71 |
| Impairment on financial assets at amortised cost (IAS 39: loans and receivables) | 82 | 72 | 19 | 63 | 78 |
| Breakdown by product | |||||
| Loans and advances | 68 | 99 | 21 | 47 | 73 |
| Debt securities | 0 | 0 | 0 | 0 | 0 |
| Provision for off-balance sheet commitments | 13 | - 27 | - 2 | 15 | 5 |
| Breakdown by type | |||||
| Loss allowance measured as 12 month ECL - stage 1 | - 11 | - | - 8 | - 3 | - |
| Loss allowance measured as lifetime ECL - stage 2 | 49 | - | 15 | 34 | - |
| Loss allowance measured as lifetime ECL - stage 3 | 43 | - | 10 | 34 | - |
| Purchased or originated credit-impaired (including off-balance-sheet credit commitments) | 0 | - | 2 | - 2 | - |
| Specific impairments for on-balance-sheet lending | - | 83 | - | - | 63 |
| Provisions for off-balance-sheet credit commitments (*) | - | - 27 | - | - | 5 |
| Portfolio-based impairments | - | 16 | - | - | 10 |
| Impairment on financial assets at fair value through OCI (IAS 39: available-for-sale assets) | 2 | - 3 | 2 | 0 | - 2 |
| Breakdown by type | |||||
| Equity instruments (2017: Shares) (**) | 0 | - 3 | 0 | - | - 2 |
| Debt securities (2017: Other) | 2 | 0 | 2 | 0 | 0 |
| - Loss allowance measured as 12 month ECL - stage 1 | 2 | - | 2 | 0 | - |
| - Loss allowance measured as lifetime ECL - stage 2 | 0 | - | 1 | 0 | - |
| - Loss allowance measured as lifetime ECL - stage 3 | 0 | - | 0 | 0 | - |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on other | - 26 | - 5 | - 20 | - 6 | - 5 |
| Intangible assets, other than goodwill | 0 | 0 | 0 | 0 | 0 |
| Property and equipment and investment property | - 26 | - 4 | - 20 | - 6 | - 4 |
| Held-to-maturity assets (IAS 39) | - | 0 | - | - | 0 |
| Modification gains/losses | 0 | 0 | 0 | 0 | 0 |
| Associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| Other | 1 | - 1 | 1 | 0 | - 1 |
* As from current year, the provisions for off-balance-sheet credit commitments are included in the lines Loss allowance per stage above.
** Under IFRS 9, equiy instruments at FVOCI are not subject to impairment calculation
In Belgium, the tax rate has decreased from 33,99% in 2017 to 29,58% in 2018 applying to the Belgian group companies, while a 100% exemption for dividends received has been introduced (instead of 95%), partly offset by the negative impact of some offsetting measures. The result of 1H 2018 has been positively impacted by these changes by approximately 65 million euros (about +25 million euros in 1Q 2018 and +40 million euros in 2Q 2018).
| Designated | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mandatorily at | at fair | |||||||||
| fair value through | value | |||||||||
| profit and loss | through | |||||||||
| Amortised | Fair value | other than Held | Held for | Available for | Loans and | Held to | profit and | Hedging | ||
| In millions of EUR | cost | through OCI | for trading | trading | sale | receivables | maturity | loss | derivatives | Total |
| FINANCIAL ASSETS, 30-06-2018 | ||||||||||
| Loans and advances to credit institutions and investment firms | ||||||||||
| excluding reverse repos | 5 057 | 0 | 0 | 1 | - | - | - | - | 0 | 5 058 |
| Loans and advances to customers excluding reverse repos | 145 246 | 0 | 86 | 0 | - | - | - | 14 | 0 | 145 346 |
| Trade receivables | 4 275 | 0 | 0 | 0 | - | - | - | 0 | 0 | 4 275 |
| Consumer credit | 4 275 | 0 | 0 | 0 | - | - | - | 0 | 0 | 4 275 |
| Mortgage loans | 60 957 | 0 | 70 | 0 | - | - | - | 0 | 0 | 61 026 |
| Term loans | 64 244 | 0 | 16 | 0 | - | - | - | 14 | 0 | 64 273 |
| Finance leasing | 5 371 | 0 | 0 | 0 | - | - | - | 0 | 0 | 5 371 |
| Current account advances | 5 326 | 0 | 0 | 0 | - | - | - | 0 | 0 | 5 326 |
| Other | 799 | 0 | 0 | 0 | - | - | - | 0 | 0 | 799 |
| Reverse repos | 25 303 | 0 | 0 | 53 | - | - | - | 0 | 0 | 25 355 |
| Reverse repos to credit institutions and investment firms | 23 646 | 0 | 0 | 53 | - | - | - | 0 | 0 | 23 699 |
| Reverse repos to customers | 1 656 | 0 | 0 | 0 | - | - | - | 0 | 0 | 1 656 |
| Equity instruments | 0 | 283 | 1 276 | 502 | - | - | - | - | - | 2 061 |
| Investment contracts (insurance) | - | - | 14 293 | - | - | - | - | - | - | 14 293 |
| Debt securities issued by | 42 349 | 18 168 | 110 | 1 247 | - | - | - | 0 | 0 | 61 875 |
| Public bodies | 36 072 | 11 880 | 0 | 1 047 | - | - | - | 0 | 0 | 48 999 |
| Credit institutions and investment firms | 3 439 | 2 624 | 9 | 117 | - | - | - | 0 | 0 | 6 189 |
| Corporates | 2 838 | 3 664 | 102 | 83 | - | - | - | 0 | 0 | 6 687 |
| Derivatives | - | - | - | 5 758 | - | - | - | - | 255 | 6 013 |
| Other | 2 150 | 0 | 0 | 19 | - | - | - | 0 | 0 | 2 169 |
| Total carrying value | 220 105 | 18 451 | 15 765 | 7 580 | - | - | - | 14 | 255 | 262 170 |
| FINANCIAL ASSETS, 31-12-2017 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Loans and advances to credit institutions and investment firms | ||||||||||
| excluding reverse repos | - | - | - | 1 | 0 | 4 877 | - | 0 | 0 | 4 878 |
| Loans and advances to customers excluding reverse repos | - | - | - | 0 | 0 | 140 960 | - | 38 | 0 | 140 999 |
| Trade receivables | - | - | - | 0 | 0 | 3 986 | - | 0 | 0 | 3 986 |
| Consumer credit | - | - | - | 0 | 0 | 3 857 | - | 0 | 0 | 3 857 |
| Mortgage loans | - | - | - | 0 | 0 | 60 601 | - | 23 | 0 | 60 625 |
| Term loans | - | - | - | 0 | 0 | 61 824 | - | 15 | 0 | 61 839 |
| Finance leasing | - | - | - | 0 | 0 | 5 308 | - | 0 | 0 | 5 308 |
| Current account advances | - | - | - | 0 | 0 | 4 728 | - | 0 | 0 | 4 728 |
| Other | - | - | - | 0 | 0 | 656 | - | 0 | 0 | 656 |
| Reverse repos | - | - | - | 2 | 0 | 20 074 | - | 0 | 0 | 20 076 |
| Reverse repos to credit institutions and investment firms | - | - | - | 2 | 0 | 19 570 | - | 0 | 0 | 19 572 |
| Reverse repos to customers | - | - | - | 0 | 0 | 504 | - | 0 | 0 | 504 |
| Equity instruments | - | - | - | 508 | 1 658 | - | - | - | - | 2 165 |
| Investment contracts (insurance) | - | - | - | - | - | - | - | 14 421 | - | 14 421 |
| Debt securities issued by | - | - | - | 1 156 | 32 498 | 921 | 30 979 | 24 | 0 | 65 578 |
| Public bodies | - | - | - | 955 | 22 307 | 52 | 29 096 | 0 | 0 | 52 410 |
| Credit institutions and investment firms | - | - | - | 121 | 4 468 | 125 | 1 177 | 0 | 0 | 5 891 |
| Corporates | - | - | - | 80 | 5 723 | 744 | 706 | 24 | 0 | 7 277 |
| Derivatives | - | - | - | 5 765 | - | - | - | - | 245 | 6 010 |
| Other | - | - | - | 0 | 0 | 626 - | 0 | 0 | 626 | |
| Total carrying value | - | - | - | 7 431 | 34 156 | 167 458 | 30 979 | 14 484 | 245 | 254 753 |
| Designated at fair | |||||
|---|---|---|---|---|---|
| Amortised | value through profit | Hedging | |||
| In millions of EUR | cost | Held for trading | and loss | derivatives | Total |
| FINANCIAL LIABILITIES, 30-06-2018 | |||||
| Deposits from credit institutions and investment firms excluding repos | 28 723 | 0 | 1 | 0 | 28 724 |
| Deposits from customers and debt certificates excluding repos | 191 203 | 206 | 1 542 | 0 | 192 951 |
| Demand deposits | 79 939 | 0 | 0 | 0 | 79 939 |
| Time deposits | 17 814 | 23 | 324 | 0 | 18 161 |
| Saving accounts | 58 899 | 0 | 0 | 0 | 58 899 |
| Special deposits | 2 426 | 0 | 0 | 0 | 2 426 |
| Other deposits | 493 | 0 | 0 | 0 | 493 |
| Certificates of deposit | 13 813 | 0 | 7 | 0 | 13 820 |
| Customer savings certificates | 1 695 | 0 | 0 | 0 | 1 695 |
| Convertible bonds | 0 | 0 | 0 | 0 | 0 |
| Non-convertible bonds | 13 695 | 182 | 1 027 | 0 | 14 904 |
| Convertible subordinated liabilities | 0 | 0 | 0 | 0 | 0 |
| Non-convertible subordinated liabilities | 2 429 | 0 | 184 | 0 | 2 612 |
| Repos | 14 821 | 91 | 0 | 0 | 14 912 |
| Repos from credit institutions | 11 678 | 91 | 0 | 0 | 11 769 |
| Repos from customers | 3 144 | 0 | 0 | 0 | 3 144 |
| Liabilities under investment contracts | 0 | 0 | 13 428 | 0 | 13 428 |
| Derivatives | 0 | 5 191 | 0 | 1 161 | 6 352 |
| Short positions | 0 | 563 | 0 | 0 | 563 |
| in equity instruments | 0 | 22 | 0 | 0 | 22 |
| in debt instruments | 0 | 540 | 0 | 0 | 540 |
| Other | 4 025 | 6 | 0 | 0 | 4 031 |
| Total carrying value | 238 772 | 6 057 | 14 971 | 1 161 | 260 962 |
| Deposits from credit institutions and investment firms excluding repos | 27 746 | 3 | 12 | 0 | 27 761 |
|---|---|---|---|---|---|
| Deposits from customers and debt certificates excluding repos | 192 019 | 219 | 1 470 | 0 | 193 708 |
| Demand deposits | 73 606 | 0 | 0 | 0 | 73 606 |
| Time deposits | 18 983 | 11 | 403 | 0 | 19 397 |
| Saving accounts | 56 692 | 0 | 0 | 0 | 56 692 |
| Special deposits | 2 235 | 0 | 0 | 0 | 2 235 |
| Other deposits | 549 | 0 | 0 | 0 | 549 |
| Certificates of deposit | 22 579 | 0 | 14 | 0 | 22 593 |
| Customer savings certificates | 1 721 | 0 | 0 | 0 | 1 721 |
| Convertible bonds | 0 | 0 | 0 | 0 | 0 |
| Non-convertible bonds | 12 323 | 208 | 866 | 0 | 13 397 |
| Convertible subordinated liabilities | 0 | 0 | 0 | 0 | 0 |
| Non-convertible subordinated liabilities | 3 330 | 0 | 186 | 0 | 3 516 |
| Repos | 5 835 | 0 | 0 | 0 | 5 836 |
| Repos from credit institutions | 5 575 | 0 | 0 | 0 | 5 575 |
| Repos from customers | 260 | 0 | 0 | 0 | 260 |
| Liabilities under investment contracts | 0 | 0 | 13 552 | 0 | 13 552 |
| Derivatives | 0 | 5 868 | 0 | 1 284 | 7 152 |
| Short positions | 0 | 905 | 0 | 0 | 905 |
| in equity instruments | 0 | 13 | 0 | 0 | 13 |
| in debt instruments | 0 | 892 | 0 | 0 | 892 |
| Other | 2 344 | 3 | 0 | 0 | 2 347 |
| Total carrying value | 227 944 | 6 998 | 15 034 | 1 284 | 251 260 |
The equity instruments for which the overlay approach is applied represent all equity instruments reported as 'Mandatorily at FVPL other than Held for trading'.
In order to provide a more transparent view on the different products, the presentation of note 4.1 has been slightly changed: (reverse) repos are as of 2018 excluded from loans and advances to credit institutions and customers (deposits from credit institutions and customers), while (reverse) repos are now presented separately. The reference figures have been restated accordingly.
Within the framework for issues of green bonds, on June 20, 2018 KBC Group launched an initial issue with a term of five years and a value of 500 million euros at a margin of 72 basis points above benchmark rate. KBC is the first Belgian financial institution to bring its own green bond into the market.
| 30-06-2018 | 31-03-2018 | |||||
|---|---|---|---|---|---|---|
| in millions of EUR Financial assets at Amortised cost |
Gross carrying amount |
Impairment carrying amount | Gross carrying amount |
Impairment | Carrying amount |
|
| Loans and advances | 180 217 | - 4 611 | 175 606 | 180 211 | - 4 669 | 175 542 |
| - Subject to 12month ECL - performing (Stage 1) | 155 487 | - 107 | 155 380 | 154 721 | - 102 | 154 618 |
| - Subject to Lifetime ECL - underperforming (Stage 2) | 15 909 | - 306 | 15 602 | 16 344 | - 329 | 16 015 |
| - Subject to Lifetime ECL - non-performing (Stage 3) | 8 652 | - 4 144 | 4 508 | 8 989 | - 4 188 | 4 801 |
| - Purchased or originated credit-impaired | 168 | - 53 | 115 | 158 | - 50 | 108 |
| Debt Securities | 42 362 | - 13 | 42 349 | 43 736 | - 14 | 43 722 |
| - Subject to 12month ECL - performing (Stage 1) | 42 118 | - 5 | 42 113 | 43 594 | - 5 | 43 589 |
| - Subject to Lifetime ECL - underperforming (Stage 2) | 236 | - 2 | 234 | 132 | - 2 | 131 |
| - Subject to Lifetime ECL - non-performing (Stage 3) | 9 | - 6 | 2 | 10 | - 8 | 2 |
| - Purchased or originated credit-impaired | 0 | 0 | 0 | 0 | 0 | 0 |
| Financial instruments at FV through OCI | ||||||
| Debt Securities | 18 175 | - 6 | 18 168 | 18 420 | - 9 | 18 411 |
| - Subject to 12month ECL - performing (Stage 1) | 17 971 | - 4 | 17 967 | 18 202 | - 6 | 18 196 |
| - Subject to Lifetime ECL - underperforming (Stage 2) | 204 | - 2 | 202 | 218 | - 3 | 216 |
| - Subject to Lifetime ECL - non-performing (Stage 3) | 0 | 0 | 0 | 0 | 0 | 0 |
| - Purchased or originated credit-impaired | 0 | 0 | 0 | 0 | 0 | 0 |
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2017.
| Fair value hierarchy | 30-06-2018 | 31-12-2017 | ||||||
|---|---|---|---|---|---|---|---|---|
| In millions of EUR | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Financial assets measured at fair value | ||||||||
| Mandatorily at fair value other than held for trading | 15 136 | 415 | 214 | 15 765 | - | - | - | - |
| Held for trading | 1 404 | 4 703 | 1 473 | 7 580 | 1 122 | 4 402 | 1 907 | 7 431 |
| Designated at fair value | 0 | 14 | 0 | 14 | 13 949 | 525 | 10 | 14 484 |
| Fair value through OCI | 14 234 | 3 817 | 400 | 18 451 | - | - | - | - |
| Available for sale | - | - | - | - | 26 374 | 6 812 | 970 | 34 156 |
| Hedging derivatives | 0 | 255 | 0 | 255 | 0 | 245 | 0 | 245 |
| Total | 30 774 | 9 203 | 2 088 | 42 065 | 41 445 | 11 984 | 2 887 | 56 316 |
| Financial liabilities measured at fair value | ||||||||
| Held for trading | 551 | 3 524 | 1 982 | 6 057 | 909 | 3 872 | 2 218 | 6 998 |
| Designated at fair value | 13 416 | 863 | 692 | 14 971 | 13 544 | 904 | 585 | 15 034 |
| Hedging derivatives | 0 | 1 161 | 0 | 1 161 | 0 | 1 284 | 0 | 1 284 |
| Total | 13 967 | 5 549 | 2 674 | 22 190 | 14 453 | 6 060 | 2 803 | 23 316 |
In the first 6 months of 2018, a total amount of 138 million euros in financial instruments at fair value was transferred from level 1 to level 2. KBC also transferred 1 002 million euros in financial instruments from level 2 to level 1. The majority of the transfers is due to changed liquidity of government and corporate bonds.
The first time application impact of the implementation of IFRS 9 resulted in an increase of 46 million euros of financial assets and liabilities measured at fair value in level 3: the largest changes are:
In the first 6 months of 2018 the following material movements are observed with respect to instruments classified in level 3 of the fair value level hierarchy:
| 30-06-2018 | 31-12-2017 | |
|---|---|---|
| in number of shares | IFRS 9 | IAS 39 |
| Ordinary shares | 418 597 567 | 418 597 567 |
| of which ordinary shares that entitle the holder to a dividend payment | 416 216 638 | 418 597 567 |
| of which treasury shares | 2 438 402 | 64 847 |
| Other information | ||
| Par value per ordinary share (in EUR) | 3,48 | 3,48 |
| Number of shares issued but not fully paid up | 0 | 0 |
The ordinary shares of KBC Group NV have no nominal value and are quoted on NYSE Euronext (Brussels).
On April 17, 2018 KBC Group NV placed 1 billion euros in Additional Tier-1 (AT1) instruments. This AT1 instrument is a 7.5-year non-call perpetual with a temporary write-down at 5.125% CET1 and an initial coupon of 4.25% per annum, payable semiannual. Since they are classified as equity instruments under IAS 32 (because interest payments are discretionary and the securities are perpetual), the annualized coupon of 4.25% – which is paid semi-annually – is treated as a dividend. This transaction had no impact on the number of ordinary shares.
The AT1 Securities have been issued in view of any potential future call of the existing 1.4 billion euros AT1 Securities issued in 2014, which KBC has the right to redeem in accordance with their terms in March 2019. The issue of the Securities enables KBC to maintain an optimal capital structure and continue to support our already excellent solvency ratios. Any decision to call the existing AT1 Securities will be taken in the context of KBC's financial position and other factors at the relevant time and will be subject to any required regulatory and other approvals and pre-conditions being satisfied.
On May 17, 2018 KBC Group NV announced a share buyback programme for the purpose of cancelling the shares. The shares were bought back under the conditions specified in the authorisation granted by the Extraordinary General Meeting of 3 May 2018. A total number of 2.700.000 of own shares were bought between 22-05-2018 and 03-07-2018 inclusive (of which (based on value date) 2 380 929 shares on 30 June 2018) , for a total amount of 181 million euros.
The treasury shares at YE 2017 almost fully relate to positions in shares of KBC Group to hedge outstanding equity derivatives.
• The acquisition of 99,91% of the shares of the United Bulgarian Bank AD and 100% of Interlease EAD in Bulgaria (balance sheet consolidated at 30 June 2017; income statement consolidated as of 1 July 2017).
Significant non-adjusting events between the balance sheet date (30 June 2018) and the publication of this report (9 August 2018):
Section not reviewed by the Auditor
The main source of credit risk is the loan portfolio of the bank. A snapshot of the banking portfolio is shown in the table below. It includes all payment credit, guarantee credit, standby credit and credit derivatives, granted by KBC to private persons, companies, governments and banks. Bonds held in the investment portfolio are included if they are corporate- or bank-issued, hence government bonds and trading book exposure are not included. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit. Information specifically on sovereign bonds can be found under 'note 6.7 (in the annual accounts 2017)'.
| Credit risk: loan portfolio overview | ||
|---|---|---|
| Total loan portfolio (in billions of EUR) | 30-06-2018 | 31-12-2017 |
| Portfolio outstanding + undrawn 1 | 207 | 191 |
| Portfolio outstanding 1 | 167 | 154 |
| Total loan portfolio, by business unit (as a % of the portfolio of credit outstanding) | ||
| Belgium | 65% | 63% |
| Czech Republic | 15% | 16% |
| International Markets | 17% | 18% |
| Group Centre | 2% | 3% |
| Total | 100% | 100% |
| Total outstanding loan portfolio sector breakdown | ||
| Private persons | ||
| Finance and insurance | 39.4% | 42.1% |
| Authorities | 7.8% 4.2% |
5.2% 2.8% |
| Corporates | 48.6% | 49.8% |
| services | 11.1% | 11.6% |
| distribution | 7.3% | 7.6% |
| real estate | 6.7% | 7.0% |
| building & construction | 4.1% | 4.2% |
| agriculture, farming, fishing automotive |
2.6% | 2.8% |
| electricity | 2.3% | 2.3% |
| food producers | 1.6% | 1.7% |
| metals | 1.5% | 1.5% |
| chemicals | 1.5% | 1.4% |
| machinery & heavy equipment | 1.2% | 1.2% |
| shipping | 1.1% | 1.1% |
| traders | 1.0% | 1.2% |
| hotels, bars & restaurants | 1.0% | 1.0% |
| oil, gas & other fuels | 0.8% | 0.8% |
| textile & apparel | 0.7% 0.6% |
0.7% 0.5% |
| electrotechnics | 0.6% | 0.6% |
| other 2 | 3.1% | 2.6% |
| Total outstanding loan portfolio geographical breakdown | ||
| Home countries | 86.0% | 88.5% |
| Belgium | 54.0% | 56.5% |
| Czech Republic | 14.8% | 14.8% |
| Ireland | 7.4% | 7.8% |
| Slovakia | 4.8% | 4.9% |
| Hungary | 3.0% | 3.3% |
| Bulgaria | 2.0% | 2.1% |
| Rest of Western Europe | 8.4% | 7.4% |
| France | 2.3% | 1.9% |
| Netherlands | 1.6% | 1.6% |
| Great Britain | 1.2% | 1.1% |
| Spain | 0.5% | 0.5% |
| Luxemburg | 0.8% | 0.6% |
| Germany | 0.7% | 0.6% |
| other Rest of Central Europe |
1.3% 0.6% |
1.1% 0.4% |
| 0.2% | 0.1% | |
| Russia other |
0.4% | 0.4% |
| North America | 1.5% | 1.4% |
| USA | 1.2% | 1.1% |
| Canada | 0.3% | 0.3% |
| Asia | 1.6% | 0.8% |
| China | 0.8% | 0.3% |
| Hong Kong | 0.2% | 0.2% |
| Singapore | 0.2% | 0.2% |
| other | 0.4% | 0.1% |
| Rest of the world | 1.9% | 1.4% |
| Loan portfolio by IFRS-9 ECL 3 stage (part of portfolio, as % of the portfolio of credit outstanding) |
||
|---|---|---|
| Stage 1 (credit risk has not increased significantly since initial recognition) | 83% | |
| of which: PD 1 - 4 | 63% | |
| of which: PD 5 - 9 including unrated | 20% | |
| Stage 2 (credit risk has increased significantly since initial recognition – not credit impaired) incl. POCI 4 | 11% | |
| of which: PD 1 - 4 | 4% | |
| of which: PD 5 - 9 including unrated | 8% | |
| Stage 3 (credit risk has increased significantly since initial recognition – credit impaired) incl. POCI 4 | 5% | |
| of which: PD 10 – 12 (impaired loans) | 5% | |
| Impaired loans (in millions of EUR or %) | ||
| Amount outstanding | 9 175 | 9 186 |
| of which: more than 90 days past due | 5 348 | 5 242 |
| Ratio of impaired loans, per business unit | ||
| Belgium | 2.4% | 2.8% |
| Czech Republic | 2.1% | 2.4% |
| International Markets | 19.5% | 19.7% |
| Group Centre | 11.4% | 9.8% |
| Total | 5.5% | 6.0% |
| of which: more than 90 days past due | 3.2% | 3.4% |
| Stage 3 loan loss impairments (in millions of EUR) and Cover ratio (%) | ||
| Stage 3 loan loss impairments | 4 403 | 4 039 |
| of which: more than 90 days past due | 3 621 | 3 361 |
| Cover ratio of impaired loans | ||
| Stage 3 loan loss impairments / impaired loans | 48% | 44% |
| of which: more than 90 days past due | 68% | 64% |
| Cover ratio of impaired loans, mortgage loans excluded | ||
| Stage 3 loan loss impairments / impaired loans, mortgage loans excluded | 57% | 54% |
| of which: more than 90 days past due | 75% | 73% |
| Credit cost, by business unit (%) | ||
| Belgium | 0.08% | 0.09% |
| Czech Republic | -0.03% | 0.02% |
| International Markets | -0.71% | -0.74% |
| Slovakia | 0.01% | 0.16% |
| Hungary | -0.28% | -0.22% |
| Bulgaria | -0.71% | 0.83% |
| Ireland | -1.30% | -1.70% |
| Group Centre | -0.93% | 0.40% |
| Total | -0.10% | -0.06% |
1 Outstanding portfolio includes all on-balance sheet commitments and off-balance sheet guarantees but excludes off-balance sheet undrawn commitments; 30-06-2018 amounts are measured in Gross Carrying Amounts; 31-12-2017 amounts are measured in the old definition of drawn principal (i.e. excluding reserved and accrued interests) 2 Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
3 Under IFRS 9 financial instruments that are subject to impairment are classified into three stages, namely Stage 1: Performing; Stage 2: Underperforming (where lifetime expected credit losses are required to be measured); and Stage 3: Non-performing or impaired; More information on these IFRS 9 stages can be found under Notes on statement of compliance and changes in accounting policies
4 Purchased or originated credit impaired assets
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2017 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the (new) definition used by EBA. Since 1Q18 a switch has been made in the reported 'outstanding' figures from drawn principal to the new IFRS 9 definition of gross carrying amount (GCA), i.e. including reserved and accrued interests. The additional inclusion of reserved interests led, among others, to an increase in the reported amount of impaired loans. Furthermore, the transaction scope of the credit portfolio was extended and now additionally includes the following 4 elements: (1) bank exposure (money market placements, documentary credit, accounts), (2) debtor risk KBC Commercial Finance, (3) unauthorized overdrafts, and (4) reverse repo (excl. central bank exposure).
In the table below the 31-12-2017 loan portfolio is restated to the extended scope:
Credit risk: loan portfolio overview
| 31/12/2017 | ||
|---|---|---|
| Total loan portfolio (in billions of EUR) | restated | 31/12/2017 |
| Total loan portfolio, by business unit | 162 | 154 |
| Belgium | 104 | 98 |
| Czech Republic | 25 | 24 |
| International Markets | 28 | 28 |
| Group Centre | 4 | 4 |
(*) restated ratios available in the section 'Details of ratios and terms on KBC Group level'
| 30-06-2018, in millions of EUR | Belgium 1 | Foreign branches | Total Business Unit Belgium | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 101 573 | 7 150 | 108 724 | |||||||
| Counterparty break down | % outst. | % outst. | % outst. | |||||||
| SME / corporate | 36 074 | 35.5% | 7 150 | 100.0% | 43 225 | 39.8% | ||||
| retail | 65 499 | 64.5% | 0 | 0.0% | 65 499 | 60.2% | ||||
| o/w private | 35 307 | 34.8% | 0 | 0.0% | 35 307 | 32.5% | ||||
| o/w companies | 30 192 | 29.7% | 0 | 0.0% | 30 192 | 27.8% | ||||
| Mortgage loans 2 | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | |||||
| total | 33 680 | 33.2% | 57% | 0 | 0.0% | - | 33 680 | 31.0% | ||
| o/w FX mortgages | 0 | 0.0% | - | 0 | 0.0% | - | 0 | 0.0% | ||
| o/w ind. LTV > 100% | 861 | 0.8% | - | 0 | 0.0% | - | 861 | 0.8% | ||
| Probability of default (PD) | % outst. | % outst. | % outst. | |||||||
| low risk (PD 1-4; 0.00%-0.80%) | 77 788 | 76.6% | 4 638 | 64.9% | 82 427 | 75.8% | ||||
| medium risk (PD 5-7; 0.80%-6.40%) | 18 343 | 18.1% | 2 111 | 29.5% | 20 453 | 18.8% | ||||
| high risk (PD 8-9; 6.40%-100.00%) | 2 733 | 2.7% | 97 | 1.4% | 2 830 | 2.6% | ||||
| impaired loans (PD 10 - 12) | 2 335 | 2.3% | 299 | 4.2% | 2 634 | 2.4% | ||||
| unrated | 374 | 0.4% | 5 | 0.1% | 379 | 0.3% | ||||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | ||||
| outstanding impaired loans | 2 335 | 1 056 | 45.2% | 299 | 154 | 51.6% | 2 634 | 1 210 | 45.9% | |
| o/w PD 10 impaired loans | 1 101 | 239 | 21.7% | 194 | 82 | 42.1% | 1 295 | 321 | 24.8% | |
| o/w more than 90 days past due (PD 11+12) | 1 234 | 817 | 66.2% | 104 | 72 | 69.2% | 1 339 | 889 | 66.4% | |
| all impairments (stage 1+2+3) | n.a. | n.a. | 1 381 | |||||||
| o/w stage 1+2 impairments (incl. POCI) | n.a. | n.a. | 172 | |||||||
| o/w stage 3 impairments (incl. POCI) | 1 056 | 154 | 1 210 | |||||||
| 2017 Credit cost ratio (CCR) | 0.08% | 0.19% | 0.09% | |||||||
| YTD 2018 CCR | 0.09% | -0.14% | 0.08% |
1 Belgium = KBC Bank (all retail and corporate credit lending activities except for the foreign branches), CBC, KBC Lease, KBC Commercial Finance, KBC Credit Investments (part of non-legacy portfolio assigned to BU Belgium)
2 Mortgage loans: only to private persons (as opposed to the accounting figures)
| 30-06-2018, in millions of EUR | For information: ČMSS 3 | |||||
|---|---|---|---|---|---|---|
| Total portfolio outstanding | 25 796 | 2 431 | (consolidated via equity-method) | |||
| Counterparty break down | % outst. | % outst. | ||||
| SME / corporate | 8 695 | 33.7% | 0 | 0.0% | ||
| retail | 17 101 | 66.3% | 2 431 | 100.0% | ||
| o/w private | 12 269 | 47.6% | 2 419 | 99.5% | ||
| o/w companies | 4 832 | 18.7% | 12 | 0.5% | ||
| Mortgage loans 1 | % outst. | ind. LTV | % outst. | ind. LTV | ||
| total | 11 058 | 42.9% | 64% | 1 895 | 77.9% | 62% |
| o/w FX mortgages | 0 | 0.0% | - | 0 | 0.0% | - |
| o/w ind. LTV > 100% | 248 | 1.0% | - | 64 | 2.7% | - |
| Probability of default (PD) | % outst. | % outst. | ||||
| low risk (PD 1-4; 0.00%-0.80%) | 16 641 | 64.5% | 1 585 | 65.2% | ||
| medium risk (PD 5-7; 0.80%-6.40%) | 7 235 | 28.0% | 617 | 25.4% | ||
| high risk (PD 8-9; 6.40%-100.00%) | 969 | 3.8% | 114 | 4.7% | ||
| impaired loans (PD 10 - 12) | 550 | 2.1% | 115 | 4.7% | ||
| unrated | 401 | 1.6% | 0 | 0.0% | ||
| Overall risk indicators 2 | stage 3 imp. | % cover | stage 3 imp. | % cover | ||
| outstanding impaired loans | 550 | 292 | 53.0% | 115 | 43 | 37.1% |
| o/w PD 10 impaired loans | 170 | 37 | 22.0% | 19 | 3 | 15.1% |
| o/w more than 90 days past due (PD 11+12) | 380 | 254 | 66.9% | 97 | 40 | 41.3% |
| all impairments (stage 1+2+3) | 377 | 49 | ||||
| o/w stage 1+2 impairments (incl. POCI) | 85 | 7 | ||||
| o/w stage 3 impairments (incl. POCI) | 292 | 43 | ||||
| 2017 Credit cost ratio (CCR) | 0.02% | 0.16% | ||||
| YTD 2018 CCR | -0.03% | -0.05% | ||||
1 Mortgage loans: only to private persons (as opposed to the accounting figures)
2 CCR at country level in local currency
3 ČMSS: pro-rata figures, corresponding with KBC's 55%-participation in ČMSS
| Loan portfolio Business Unit International Markets | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-06-2018, in millions of EUR | Ireland | Slovakia | Hungary | Bulgaria | Total Int Markets | ||||||||||
| Total portfolio outstanding | 12 374 | 7631 | 4957 | 3377 | 28 3 39 | ||||||||||
| Counteroartybreak down | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| SME / corporate | 1 140 | 9.2% | 2935 | 38.5% | 2965 | 59.8% | 1076 | 31.9% | 8 1 1 7 | 28.6% | |||||
| retail | 11 233 | 90.8% | 4696 | 61.5% | 1992 | 40.2% | 2301 | 68.1% | 20 222 | 71.4% | |||||
| o/w private | 11 222 | 90.7% | 3802 | 49.8% | 1828 | 36.9% | 1292 | 38.3% | 18 145 | 64.0% | |||||
| o/w companies | 11 | 0.1% | 894 | 11.7% | 164 | 3.3% | 1009 | 29.9% | 2077 | 7.3% | |||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ||||||
| total | 11 172 | 90.3% | 74% | 3297 | 43.2% | 65% | 1656 | 33.4% | 64% | 682 | 20.2% | 69% | 16 807 | 59.3% | |
| o/w FX mortgages | 0 | 0.0% | 0 | 0.0% | 11 | 0.2% | 119% | 113 | 3.3% | 61% | 124 | 0.4% | |||
| o/w ind. LTV > 100% | 1606 | 13.0% | 19 | 0.2% | 230 | 4.6% | 59 | 1.8% | 1914 | 6.8% | |||||
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 879 | 7.1% | 4718 | 61.8% | 2617 | 52.8% | 889 | 26.3% | 9 10 3 | 32.1% | |||||
| medium risk (PD 5-7; 0.80%-6.40%) | 6 0 0 5 | 48.5% | 2 1 8 1 | 28.6% | 1831 | 36.9% | 1510 | 44.7% | 11 526 | 40.7% | |||||
| high risk (PD 8-9; 6.40%-100.00%) | 1095 | 8.9% | 483 | 6.3% | 202 | 4.1% | 317 | 9.4% | 2 0 9 7 | 7.4% | |||||
| impaired loans (PD 10 - 12) | 4 3 9 5 | 35.5% | 193 | 2.5% | 306 | 6.2% | 630 | 18.7% | 5 5 24 | 19.5% | |||||
| unrated | o | 0.0% | 57 | 0.7% | 0.0% | 31 | 0.9% | 88 | 0.3% | ||||||
| Overall risk indicators 2 | spec. imp. | % cover | spec. imp. | % cover | spec. mp. | % cover | spec. imp. | % cover | spec. imp. | % cover | |||||
| outstanding impaired loans | 4 3 9 5 | 1820 | 41.4% | 193 | 144 | 74.9% | 306 | 202 | 65.9% | 630 | 374 | 59.4% | 5 5 24 | 2.541 | 46.0% |
| o/w PD 10 impaired loans | 2 1 2 0 | 355 | 16.8% | 23 | 12 | 52.3% | 45 | 17 | 38.3% | 71 | 18 | 24.9% | 2 259 | 402 | 17.8% |
| o/w more than 90 days past due (PD 11+12) | 2 2 7 5 | 1465 | 64.4% | 169 | 132 | 78.0% | 262 | 185 | 70.6% | 559 | 357 | 63.7% | 3 2 8 5 | 2 139 | 65.5% |
| all impairments (stage 1+2+3) | 1864 | 192 | 226 | 403 | 2 685 | ||||||||||
| o/w stage 1+2 impairments (incl. POC) | 44 | 47 | 24 | 29 | 144 | ||||||||||
| o/w stage 3 impairments (ind. POCI) | 1820 | 144 | 202 | 374 | 2 5 41 | ||||||||||
| 2017 Credit cost ratio (CCR) | $-1.70%$ | 0.16% | $-0.22\%$ | 0.83% | $-0.74%$ | ||||||||||
| YTD 2018 CCR | $-1.30\%$ | 0.01% | $-0.28%$ | $-0.71%$ | $-0.71%$ | ||||||||||
| Total portfolio outstanding | 4 090 | ||
|---|---|---|---|
| Counterparty break down | % outst. | ||
| SME / corporate | 4 090 | 100.0% | |
| retail | 0 | 0.0% | |
| o/w private | 0 | 0.0% | |
| o/w companies | 0 | 0.0% | |
| Mortgage loans 2 | % outst. | ind. LTV | |
| total | 0 | 0.0% | - |
| o/w FX mortgages | 0 | 0.0% | - |
| o/w ind. LTV > 100% | 0 | 0.0% | - |
| Probability of default (PD) | % outst. | ||
| low risk (PD 1-4; 0.00%-0.80%) | 3 106 | 75.9% | |
| medium risk (PD 5-7; 0.80%-6.40%) | 431 | 10.5% | |
| high risk (PD 8-9; 6.40%-100.00%) | 86 | 2.1% | |
| impaired loans (PD 10 - 12) | 467 | 11.4% | |
| unrated | 0 | 0.0% | |
| Overall risk indicators | stage 3 imp. | % cover | |
| outstanding impaired loans | 467 | 361 | 77.3% |
| o/w PD 10 impaired loans | 103 | 21 | 20.8% |
| o/w more than 90 days past due (PD 11+12) | 364 | 340 | 93.3% |
| all impairments (stage 1+2+3) | 405 | ||
| o/w stage 1+2 impairments (incl. POCI) | 44 | ||
| o/w stage 3 impairments (incl. POCI) | 361 | ||
| 2017 Credit cost ratio (CCR) | 0.40% | ||
| YTD 2018 CCR | -0.93% |
1 Total Group Centre = KBC Credit Investments (part of non-legacy portfolio assigned to BU Group) and KBC Bank part Group (a.o. activities in wind-down: e.g. ex-Antwerp Diamond Bank)
2 Mortgage loans: only to private persons (as opposed to the accounting figures)
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD IV. This regulation entered gradually into force on 1 January 2014. The general rule under CRR/CRD IV for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). KBC received such permission from the supervisory authority and hence reports its solvency on the basis of a 370% risk weighting being applied to the holdings of own fund instruments of the insurance company, after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRD IV/CRR, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC. This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD IV for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculate KBC's risk weighted assets. This is, based on a full application of all the CRD IV/CRR rules, used for approximately 92% of the weighted credit risks, of which approx. 86% according to Advanced and approx. 6% according to Foundation approach. The remaining weighted credit risks (ca. 8%) are calculated according to the Standardised approach.
The minimum CET1 requirement that KBC is to uphold is set at 10.6% (fully loaded, Danish Compromise) which includes the CRR/CRD IV minimum requirement (4.5%), the Pillar 2 Requirement (1.75%) and the buffers set by national competent authorities (2.50% Capital Conservation Buffer, 1.50% Systemic Buffer and 0.35% Countercycle Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.00%. For further information see press release of 22 February 2018 on www.kbc.com.
Note that as from 01/01/2018 onwards, there is no difference anymore between fully loaded and phased-in.
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| numerator (common equity) |
denominator (total weighted risk volume) |
ratio (%) | ||
|---|---|---|---|---|
| CRDIV, Common Equity ratio | ||||
| Danish Compromise | Fully loaded | 14 715 | 92 931 | 15,83% |
| Deduction Method | Fully loaded | 13 721 | 87 484 | 15,68% |
| Financial Conglomerates Directive | Fully loaded | 15 826 | 105 764 | 14,96% |
| Pro forma (**) | ||||
|---|---|---|---|---|
| 30-06-2018 | 31-03-2018 | 31-12-2017 | 01-01-2018 | |
| In millions of EUR | Fully loaded | Fully loaded | Fully loaded | Fully loaded |
| Total regulatory capital (after profit appropriation) | 19 336 | 18 332 | 18 706 | 18 348 |
| Tier-1 capital | 17 115 | 16 193 | 16 504 | 16 099 |
| Common equity | 14 715 | 14 793 | 15 104 | 14 699 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 16 104 | 16 707 | 16 841 | 16 244 |
| Intangible fixed assets (incl deferred tax impact) (-) | - 507 | - 492 | - 475 | - 475 |
| Goodwill on consolidation (incl deferred tax impact) (-) | - 595 | - 604 | - 604 | - 604 |
| Minority interests | 0 | 0 | 0 | |
| Hedging reserve (cash flow hedges) (-) | 1 321 | 1 291 | 1 339 | 1 339 |
| Valuation diff. in fin. liabilities at fair value - own credit risk (-) | - 12 | - 5 | - 1 | - 1 |
| Value adjustment due to the requirements for prudent valuation (-) | - 75 | - 76 | - 124 | - 77 |
| Dividend payout (-) | - 608 | - 1 108 | - 837 | - 837 |
| Share buyback (part not yet executed) (-) | - 21 | |||
| Renumeration of AT1 instruments (-) | - 7 | - 2 | - 2 | - 2 |
| Deduction re. financing provided to shareholders (-) | - 91 | - 91 | - 91 | - 91 |
| Deduction re. Irrevocable payment commitments (-) | - 32 | - 20 | ||
| IRB provision shortfall (-) | - 89 | - 88 | - 268 | - 84 |
| Deferred tax assets on losses carried forward (-) | - 672 | - 719 | - 672 | - 712 |
| Limit on deferred tax assets from timing differences relying on future profitability | ||||
| and significant participations in financial sector entities (-) | 0 | 0 | 0 | |
| Additional going concern capital | 2 400 | 1 400 | 1 400 | 1 400 |
| Grandfathered innovative hybrid tier-1 instruments | 0 | 0 | 0 | 0 |
| (***) CRR compliant AT1 instruments |
2 400 | 1 400 | 1 400 | 1 400 |
| Minority interests to be included in additional going concern capital | 0 | 0 | 0 | 0 |
| Tier 2 capital | 2 221 | 2 138 | 2 202 | 2 249 |
| IRB provision excess (+) | 360 | 257 | 316 | 363 |
| Subordinated liabilities | 1 861 | 1 881 | 1 886 | 1 886 |
| Subordinated loans non-consolidated financial sector entities (-) | 0 | 0 | 0 | 0 |
| Minority interests to be included in tier 2 capital | 0 | 0 | 0 | 0 |
| Total weighted risk volume | 92 931 | 93 173 | 92 410 | 92 276 |
| Banking | 83 624 | 83 873 | 83 117 | |
| Insurance | 9 133 | 9 133 | 9 133 | |
| Holding activities | 219 | 213 | 202 | |
| Elimination of intercompany transactions | - 46 | - 47 | - 43 | |
| Solvency ratios | ||||
| Common equity ratio | 15,83% | 15,88% | 16,34% | 15,93% |
| Tier-1 ratio | 18,42% | 17,38% | 17,86% | 17,45% |
| Total capital ratio (*) | 20,81% | 19,68% | 20,24% | 19,88% |
(*) We have called the USD contingent convertible note (CoCo) the 25th of January 2018. The capital value of the CoCo has already been excluded from Tier-2 at year-end 2017. The impact of the CoCo call is largely offset by the successful issue of a Tier 2 benchmark issue in September 2017.
(**) Including first time application of IFRS 9
(***) On April 17, 2018 KBC Group NV placed 1 billion euros in Additional Tier-1 (AT1) instruments
| In millions of EUR | 31-06-2018 | 31-03-2018 | 31-12-2017 |
|---|---|---|---|
| Tier-1 capital (Danish compromise) | 17 115 | 16 193 | 16 504 |
| Total exposures | 284 108 | 285 110 | 272 373 |
| Total Assets | 301 934 | 304 022 | 292 342 |
| Deconsolidation KBC Insurance | -32 158 | -32 044 | -32 802 |
| Adjustment for derivatives | -3 925 | -3 059 | -3 908 |
| Adjustment for regulatory corrections in determining Basel III Tier-1 capital | -2 061 | -2 070 | -2 235 |
| Adjustment for securities financing transaction exposures | 2 500 | 749 | 816 |
| Off-balance sheet exposures | 17 817 | 17 511 | 18 160 |
| Leverage ratio | 6,02% | 5,68% | 6,06% |
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD IV. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016.
The tables below show the tier-1 and CAD ratios calculated under Basel III (CRD IV/CRR) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| KBC Bank consolidated - CRDIV/CRR | 30/06/2018 | 31-03-2018 | 31-12-2017 |
|---|---|---|---|
| In millions of EUR | Fully loaded | Fully loaded | Fully loaded |
| Total regulatory capital, after profit appropriation | 16 617 | 15 391 | 15 756 |
| Tier-1 capital | 14 319 | 13 192 | 13 484 |
| Of which common equity | 11 913 | 11 786 | 12 077 |
| Tier-2 capital | 2 298 | 2 199 | 2 273 |
| Total weighted risks | 83 624 | 83 873 | 83 117 |
| Credit risk | 69 652 | 69 677 | 68 842 |
| Market risk | 3 059 | 3 283 | 3 361 |
| Operational risk | 10 913 | 10 913 | 10 913 |
| Solvency ratios | |||
| Common equity ratio | 14,2% | 14,1% | 14,5% |
| Tier-1 ratio | 17,1% | 15,7% | 16,2% |
| CAD ratio | 19,9% | 18,4% | 19,0% |
(*) We have called the USD contingent convertible note (CoCo) the 25th of January 2018. The capital value of the coco has been excluded from Tier-2 at yearend 2017.
| In millions of EUR | 30-06-2018 | 31-03-2018 | 31-12-2017 |
|---|---|---|---|
| Own Funds | 3 855 | 3 894 | 3 865 |
| Tier 1 | 3 355 | 3 394 | 3 365 |
| IFRS Parent shareholders equity | 2 993 | 2 892 | 3 051 |
| Dividend payout | - 236 | - 96 | - 8 |
| Deduction intangible assets and goodwill (after tax) | - 129 | - 128 | - 128 |
| Valuation differences (after tax) | 603 | 689 | 403 |
| Volatility adjustment | 131 | 42 | 43 |
| Other | - 7 | - 5 | 3 |
| Tier 2 | 500 | 500 | 500 |
| Subordinated liabilities | 500 | 500 | 500 |
| Solvency Capital Requirement (SCR) | 1 757 | 1 783 | 1 823 |
| Market risk | 1 516 | 1 542 | 1 602 |
| Non-life | 535 | 536 | 535 |
| Life | 655 | 652 | 630 |
| Health | 169 | 169 | 178 |
| Counterparty | 117 | 126 | 107 |
| Diversification | - 908 | - 915 | - 905 |
| Other | - 326 | - 327 | - 324 |
| Solvency II ratio | 219% | 218% | 212% |
| Solvency surplus vs 100% | 2 097 | 2 111 | 2 042 |
Besides the ECB and NBB, which supervise KBC on a going concern basis, KBC is also subject to requirements set by the Single Resolution Board (SRB). The SRB is developing resolution plans for the major banks in the euro area. The resolution plan for KBC is based on a Single Point of Entry (SPE) approach at the level of KBC Group with 'bail-in' as the primary resolution tool.
MREL measures the amount of own funds and eligible liabilities that can be credibly and feasibly bailed-in. At 30-06-2018, the MREL ratio based on instruments issued by KBC Group NV ('HoldCo MREL') stood at 25.1% of risk weighted assets. Based on the broader SRB definition including also eligible OpCo instruments, the MREL ratio amounts to 26.4%. SRB requires KBC to achieve 25.9% by 01-05-2019 using both HoldCo and eligible OpCo instruments.
Details on our segments or business units are available in the company presentation
| Breakdown P&L | IFRS 9 | IFRS 9 | IAS 39 | IAS 39 | IAS 39 |
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 4Q 2017 | 3Q 2017 | 2Q 2017 |
| Net interest income | 642 | 649 | 569 | 589 | 611 |
| Non-life insurance before reinsurance | 144 | 103 | 100 | 153 | 131 |
| Earned premiums Non-life | 265 | 259 | 265 | 263 | 258 |
| Technical charges Non-life | -121 | -156 | -165 | -111 | -127 |
| Life insurance before reinsurance | -22 | -27 | -24 | -21 | -43 |
| Earned premiums Life | 234 | 251 | 292 | 195 | 199 |
| Technical charges Life | -257 | -278 | -316 | -216 | -242 |
| Ceded reinsurance result | -8 | -4 | -9 | 4 | -7 |
| Dividend income | 29 | 21 | 7 | 9 | 24 |
| Net result from financial instruments at fair value through profit or loss | 54 | 34 | 150 | 106 | 127 |
| Net realised result from available-for-sale assets | 34 | 34 | 32 | ||
| Net realised result from debt instr FV through OCI | 0 | 0 | |||
| Net fee and commission income | 302 | 318 | 313 | 301 | 331 |
| Net other income | 49 | 59 | 38 | 51 | 40 |
| TOTAL INCOME | 1 189 | 1 153 | 1 178 | 1 225 | 1 245 |
| Operating expenses | -562 | -822 | -566 | -520 | -544 |
| Impairment | -26 | -13 | -24 | -34 | 2 |
| on loans and receivable | -12 | -21 | 4 | ||
| on impairment on FA at AC | -27 | -14 | |||
| on available-for-sale | -3 | -5 | -2 | ||
| on impairment on FA at FV though OCI | 1 | 1 | |||
| on other | 0 | 0 | -9 | -8 | -1 |
| Share in results of associated companies and joint ventures | -4 | -1 | -9 | 0 | -4 |
| RESULT BEFORE TAX | 597 | 316 | 579 | 672 | 698 |
| Income tax expense | -159 | -73 | -243 | -217 | -215 |
| RESULT AFTER TAX | 437 | 243 | 335 | 455 | 484 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 437 | 243 | 336 | 455 | 483 |
| Banking | 302 | 165 | 271 | 336 | 385 |
| Insurance | 135 | 78 | 65 | 119 | 98 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 98 258 | 95 710 | 94 495 | 93 512 | 93 494 |
| Mortgage loans (end of period) | 34 627 | 34 548 | 34 468 | 34 222 | 34 079 |
| Customer deposits and debt certificates excl. repos (end of period) | 131 013 | 126 694 | 132 881 | 128 895 | 129 825 |
| Technial provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed | 13 382 | 13 496 | 13 649 | 13 775 | 13 940 |
| Unit-Linked | 13 269 | 13 160 | 13 370 | 13 115 | 13 161 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 46 848 | 46 553 | 44 611 | 43 988 | 43 329 |
| Required capital, insurance (end of period) | 1 560 | 1 570 | 1 627 | 1 503 | 1 444 |
| Allocated capital (end of period) | 6 526 | 6 505 | 6 267 | 6 078 | 5 950 |
| Return on allocated capital (ROAC) | 27% | 15% | 22% | 30% | 32% |
| Cost/income ratio, banking | 51% | 76% | 49% | 46% | 45% |
| Combined ratio, non-life insurance | 83% | 93% | 104% | 78% | 86% |
| Net interest margin, banking | 1,72% | 1,73% | 1,48% | 1,51% | 1,61% |
| Breakdown P&L | IFRS 9 | iFRS 9 | IAS 39 | IAS 39 | IAS 39 | IAS 39 | IAS 39 |
|---|---|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 4Q 2017 | 3Q 2017 | 2Q 2017 | 1Q 2017 | FY 2016 |
| Net interest income | 241 | 248 | 234 | 218 | 220 | 216 | 849 |
| Non-life insurance before reinsurance | 24 | 27 | 21 | 25 | 22 | 18 | 78 |
| Earned premiums Non-life | 62 | 57 | 59 | 56 | 53 | 49 | 190 |
| Technical charges Non-life | -38 | -30 | -38 | -31 | -31 | -30 | -112 |
| Life insurance before reinsurance | 15 | 15 | 14 | 12 | 12 | 11 | -346 |
| Earned premiums Life | 58 | 60 | 96 | 68 | 47 | 48 | 271 |
| Technical charges Life | -43 | -46 | -83 | -56 | -35 | -38 | -234 |
| Ceded reinsurance result | -2 | -3 | 2 | -2 | -2 | -1 | -4 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 8 | 40 | 54 | 53 | 65 | 50 | 117 |
| Net realised result from available-for-sale assets | 0 | -1 | 6 | 11 | 48 | ||
| Net realised result from debt instr FV through OCI | 0 | 0 | |||||
| Net fee and commission income | 64 | 67 | 53 | 43 | 47 | 47 | 191 |
| Net other income | 3 | 4 | 4 | 5 | 5 | 26 | 18 |
| TOTAL INCOME | 353 | 398 | 383 | 354 | 375 | 378 | 1 333 |
| Operating expenses | -173 | -189 | -177 | -153 | -151 | -165 | -608 |
| Impairment | -9 | -7 | -11 | -3 | -11 | 1 | -24 |
| on loans and receivable | 2 | -1 | -7 | 1 | -23 | ||
| on impairment on FA at AC | 4 | -1 | |||||
| on available-for-sale | -1 | 0 | 0 | 0 | 3 | ||
| on impairment on FA at FV though OCI | 0 | 0 | |||||
| on other | -13 | -6 | -12 | -2 | -3 | 0 | -4 |
| Share in results of associated companies and joint ventures | 6 | 6 | 5 | 6 | 6 | 4 | 23 |
| RESULT BEFORE TAX | 177 | 207 | 200 | 205 | 219 | 218 | 724 |
| Income tax expense | -33 | -36 | -33 | -34 | -37 | -37 | -128 |
| RESULT AFTER TAX | 145 | 171 | 167 | 170 | 183 | 181 | 596 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 145 | 171 | 167 | 170 | 183 | 181 | 596 |
| Banking | 137 | 160 | 157 | 162 | 176 | 174 | 564 |
| Insurance | 7 | 12 | 10 | 9 | 7 | 7 | 32 |
| Breakdown Loans and deposits | |||||||
| Total customer loans excluding reverse repo (end of period) | 22 751 | 22 656 | 22 303 | 22 155 | 21 520 | 20 253 | 19 552 |
| Mortgage loans (end of period) | 10 784 | 10 837 | 10 653 | 10 245 | 9 867 | 9 273 | 9 077 |
| Customer deposits and debt certificates excl. repos (end of period) | 30 868 | 30 552 | 30 246 | 29 529 | 28 925 | 27 770 | 26 183 |
| Technial provisions plus unit-linked, life insurance | |||||||
| Interest Guaranteed | 603 | 617 | 613 | 601 | 594 | 576 | 575 |
| Unit-Linked | 623 | 623 | 622 | 556 | 549 | 525 | 525 |
| Performance Indicators | |||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 14 717 | 14 683 | 15 397 | 14 855 | 15 039 | 14 386 | 13 748 |
| Required capital, insurance (end of period) | 122 | 127 | 114 | 118 | 116 | 110 | 103 |
| Allocated capital (end of period) | 1 682 | 1 683 | 1 716 | 1 662 | 1 680 | 1 606 | 1 504 |
| Return on allocated capital (ROAC) | 34% | 40% | 40% | 42% | 47% | 48% | 37% |
| Cost/income ratio, banking | 48% | 47% | 45% | 42% | 39% | 43% | 45% |
| Combined ratio, non-life insurance | 99% | 92% | 96% | 95% | 97% | 100% | 96% |
| Net interest margin, banking | 2,97% | 3,02% | 3,06% | 2,85% | 3,01% | 3,06% | 2,94% |
| Breakdown P&L | IFRS 9 | IFRS 9 | IAS 39 | IAS 39 | IAS 39 | IAS 39 |
|---|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 2017 | 4Q 2017 | 3Q 2017 | 2Q 2017 |
| Net interest income | 222 | 226 | 837 | 228 | 226 | 194 |
| Non-life insurance before reinsurance | 31 | 26 | 83 | 27 | 8 | 23 |
| Earned premiums Non-life | 62 | 58 | 224 | 57 | 56 | 57 |
| Technical charges Non-life | -31 | -32 | -141 | -31 | -48 | -34 |
| Life insurance before reinsurance | 9 | 6 | -201 | 7 | 6 | 6 |
| Earned premiums Life | 24 | 25 | 85 | 23 | 18 | 21 |
| Technical charges Life | -15 | -19 | -60 | -16 | -12 | -15 |
| Ceded reinsurance result | -5 | -2 | 9 | -2 | 13 | 0 |
| Dividend income | 0 | 0 | 1 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 24 | 18 | 95 | 23 | 25 | 19 |
| Net realised result from available-for-sale assets | 3 | 0 | 1 | 0 | ||
| Net realised result from debt instr FV through OCI | 0 | 1 | ||||
| Net fee and commission income | 73 | 68 | 232 | 65 | 65 | 54 |
| Net other income | 8 | 8 | -112 | -60 | -57 | 1 |
| TOTAL INCOME | 364 | 350 | 1 173 | 288 | 287 | 297 |
| Operating expenses | -209 | -252 | -837 | -236 | -206 | -183 |
| Impairment | 33 | 61 | 190 | 39 | 11 | 92 |
| on loans and receivable | 197 | 45 | 12 | 92 | ||
| on impairment on FA at AC | 39 | 61 | ||||
| on available-for-sale | -1 | 0 | -1 | 0 | ||
| on impairment on FA at FV though OCI | 0 | 0 | ||||
| on other | -6 | 0 | -7 | -5 | -1 | -1 |
| Share in results of associated companies and joint ventures | 1 | 2 | 4 | 0 | 2 | 1 |
| RESULT BEFORE TAX | 189 | 160 | 529 | 91 | 94 | 207 |
| Income tax expense | -26 | -24 | -85 | -17 | -15 | -30 |
| RESULT AFTER TAX | 163 | 137 | 444 | 74 | 78 | 177 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 163 | 137 | 444 | 74 | 78 | 177 |
| Banking | 153 | 127 | 415 | 68 | 71 | 171 |
| Insurance | 10 | 9 | 29 | 6 | 7 | 6 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 24 336 | 24 146 | 24 201 | 24 201 | 23 871 | 23 508 |
| Mortgage loans (end of period) | 15 616 | 15 559 | 15 503 | 15 503 | 14 850 | 14 661 |
| Customer deposits and debt certificates excl. repos (end of period) | 22 693 | 22 957 | 22 663 | 22 663 | 22 056 | 21 714 |
| Technial provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed | 247 | 248 | 212 | 212 | 212 | 215 |
| Unit-Linked | 402 | 423 | 429 | 429 | 422 | 419 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 19 402 | 19 506 | 19 790 | 19 790 | 19 923 | 19 991 |
| Required capital, insurance (end of period) | 98 | 100 | 104 | 104 | 97 | 94 |
| Allocated capital (end of period) | 2 155 | 2 167 | 2 162 | 2 162 | 2 169 | 2 173 |
| Return on allocated capital (ROAC) | 30% | 25% | 18% | 14% | 16% | 36% |
| Cost/income ratio, banking | 58% | 73% | 72% | 83% | 72% | 61% |
| Combined ratio, non-life insurance | 90% | 86% | 93% | 94% | 98% | 93% |
| Net interest margin, banking | 2,81% | 2,88% | 2,77% | 2,84% | 2,83% | 2,72% |
| Breakdown P&L | IFRS 9 | IFRS 9 | IAS 39 | IAS 39 | IAS 39 |
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 4Q 2017 | 3Q 2017 | 2Q 2017 |
| Net interest income | 60 | 61 | 63 | 63 | 60 |
| Non-life insurance before reinsurance | 10 | 11 | 8 | 9 | 9 |
| Earned premiums Non-life | 27 | 26 | 26 | 26 | 25 |
| Technical charges Non-life | -17 | -15 | -17 | -17 | -15 |
| Life insurance before reinsurance | 3 | 1 | 2 | 2 | 2 |
| Earned premiums Life | 4 | 4 | 4 | 4 | 4 |
| Technical charges Life | -1 | -3 | -2 | -2 | -2 |
| Ceded reinsurance result | -1 | -1 | 0 | 0 | -1 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 20 | 14 | 15 | 14 | 14 |
| Net realised result from available-for-sale assets | 0 | 0 | 0 | ||
| Net realised result from debt instr FV through OCI | 0 | 0 | |||
| Net fee and commission income | 51 | 46 | 43 | 41 | 41 |
| Net other income | 6 | 7 | 3 | 1 | -1 |
| TOTAL INCOME | 150 | 139 | 134 | 129 | 124 |
| Operating expenses | -80 | -103 | -86 | -81 | -77 |
| Impairment | 2 | 6 | -1 | -1 | 8 |
| on loans and receivable | 1 | 0 | 9 | ||
| on impairment on FA at AC | 2 | 6 | |||
| on available-for-sale on impairment on FA at FV though OCI |
0 | 0 | 0 | 0 | 0 |
| on other | 0 | 0 | -2 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 71 | 41 | 47 | 47 | 55 |
| Income tax expense | -10 | -7 | -7 | -8 | -8 |
| RESULT AFTER TAX | 62 | 34 | 39 | 40 | 47 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 62 | 34 | 39 | 40 | 47 |
| Banking | 58 | 31 | 37 | 37 | 46 |
| Insurance | 4 | 3 | 3 | 2 | 2 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 4 112 | 4 173 | 4 217 | 4 073 | 3 893 |
| Mortgage loans (end of period) | 1 481 | 1 543 | 1 556 | 1 532 | 1 494 |
| Customer deposits and debt certificates excl. repos (end of period) | 6 972 | 7 053 | 7 302 | 6 980 | 6 663 |
| Technial provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed | 54 | 56 | 55 | 55 | 55 |
| Unit-Linked | 269 | 289 | 298 | 291 | 290 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 5 938 | 6 103 | 5 799 | 5 671 | 5 379 |
| Required capital, insurance (end of period) | 35 | 36 | 37 | 36 | 34 |
| Allocated capital (end of period) | 665 | 683 | 640 | 626 | 593 |
| Return on allocated capital (ROAC) | 37% | 21% | 26% | 25% | 30% |
| Cost/income ratio, banking | 53% | 76% | 64% | 63% | 62% |
| Combined ratio, non-life insurance | 93% | 84% | 101% | 99% | 92% |
| Slovakia | |||||
|---|---|---|---|---|---|
| Breakdown P&L | IFRS 9 | IFRS 9 | IAS 39 | IAS 39 | IAS 39 |
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 4Q 2017 | 3Q 2017 | 2Q 2017 |
| Net interest income | 52 | 52 | 53 | 52 | 53 |
| Non-life insurance before reinsurance | 6 | 6 | 7 | 6 | 6 |
| Earned premiums Non-life | 10 | 10 | 10 | 9 | 9 |
| Technical charges Non-life | -3 | -4 | -3 | -3 | -3 |
| Life insurance before reinsurance | 3 | 3 | 3 | 3 | 3 |
| Earned premiums Life | 13 | 14 | 13 | 10 | 13 |
| Technical charges Life | -10 | -11 | -10 | -7 | -10 |
| Ceded reinsurance result | -1 | -1 | -1 | 0 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 0 | 3 | 3 | 3 | 5 |
| Net realised result from available-for-sale assets | 0 | 0 | 0 | ||
| Net realised result from debt instr FV through OCI | 0 | 0 | |||
| Net fee and commission income | 15 | 14 | 13 | 12 | 13 |
| Net other income | 2 | 1 | 2 | 2 | 2 |
| TOTAL INCOME | 78 | 78 | 80 | 77 | 82 |
| Operating expenses | -50 | -52 | -56 | -48 | -49 |
| Impairment | -4 | 4 | -3 | -7 | -1 |
| on loans and receivable | -2 | -7 | -1 | ||
| on impairment on FA at AC | -4 | 4 | |||
| on available-for-sale | 0 | 0 | 0 | ||
| on impairment on FA at FV though OCI | 0 | 0 | |||
| on other Share in results of associated companies and joint ventures |
0 0 |
0 0 |
-1 0 |
0 0 |
0 0 |
| RESULT BEFORE TAX | 24 | 29 | 21 | 22 | 32 |
| Income tax expense | -6 | -6 | -5 | -5 | -7 |
| RESULT AFTER TAX | 19 | 23 | 16 | 16 | 25 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 19 | 23 | 16 | 16 | 25 |
| Banking | 16 | 21 | 14 | 14 | 22 |
| Insurance | 3 | 2 | 2 | 3 | 3 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 6 861 | 6 640 | 6 574 | 6 434 | 6 284 |
| Mortgage loans (end of period) | 3 123 | 3 021 | 2 943 | 2 861 | 2 770 |
| Customer deposits and debt certificates excl. repos (end of period) | 6 205 | 6 259 | 6 066 | 5 714 | 5 820 |
| Technial provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed | 114 | 114 | 114 | 113 | 113 |
| Unit-Linked | 116 | 121 | 124 | 126 | 125 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 4 922 | 4 911 | 4 908 | 4 826 | 4 910 |
| Required capital, insurance (end of period) | 25 | 27 | 26 | 23 | 23 |
| Allocated capital (end of period) | 546 | 548 | 537 | 525 | 534 |
| Return on allocated capital (ROAC) | 14% | 17% | 12% | 13% | 19% |
| Cost/income ratio, banking | 64% | 67% | 70% | 64% | 60% |
| Combined ratio, non-life insurance | 82% | 87% | 88% | 85% | 82% |
| Bulgaria | |||||
|---|---|---|---|---|---|
| Breakdown P&L | IFRS 9 | IFRS 9 | IAS 39 | IAS 39 | IAS 39 |
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 4Q 2017 | 3Q 2017 | 2Q 2017 |
| Net interest income | 37 | 39 | 39 | 40 | 12 |
| Non-life insurance before reinsurance | 15 | 10 | 12 | -7 | 8 |
| Earned premiums Non-life | 25 | 23 | 22 | 21 | 24 |
| Technical charges Non-life | -11 | -13 | -10 | -28 | -16 |
| Life insurance before reinsurance | 3 | 1 | 2 | 1 | 1 |
| Earned premiums Life | 7 | 6 | 6 | 4 | 4 |
| Technical charges Life | -4 | -5 | -4 | -2 | -3 |
| Ceded reinsurance result | -4 | -1 | -1 | 14 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 3 | 2 | 5 | 7 | 1 |
| Net realised result from available-for-sale assets | 0 | 1 | 0 | ||
| Net realised result from debt instr FV through OCI | 0 | 1 | |||
| Net fee and commission income | 8 | 9 | 10 | 11 | -1 |
| Net other income | 0 | -1 | 0 | -4 | 1 |
| TOTAL INCOME | 62 | 60 | 65 | 64 | 22 |
| Operating expenses | -31 | -46 | -35 | -33 | -13 |
| Impairment | -3 | 9 | -9 | -7 | -3 |
| on loans and receivable | -7 | -7 | -3 | ||
| on impairment on FA at AC | 3 | 9 | |||
| on available-for-sale | 0 | -1 | 0 | ||
| on impairment on FA at FV though OCI | 0 | 0 | |||
| on other | -6 | 0 | -2 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 1 | -1 | 1 | 0 |
| RESULT BEFORE TAX | 29 | 23 | 21 | 25 | 6 |
| Income tax expense | -3 | -2 | -2 | -3 | 0 |
| RESULT AFTER TAX | 26 | 21 | 19 | 22 | 5 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent Banking |
26 23 |
21 18 |
18 17 |
22 21 |
5 4 |
| Insurance | 3 | 3 | 2 | 1 | 1 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 2 772 | 2 739 | 2 716 | 2 695 | 2 684 |
| Mortgage loans (end of period) | 1 102 | 1 113 | 1 100 | 660 | 657 |
| Customer deposits and debt certificates excl. repos (end of period) | 3 976 | 4 009 | 3 903 | 3 998 | 3 846 |
| Technial provisions plus unit-linked, life insurance | |||||
| Interest Guaranteed | 79 | 78 | 43 | 44 | 47 |
| Unit-Linked | 17 | 13 | 7 | 5 | 4 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 3 045 | 2 990 | 2 933 | 2 886 | 3 037 |
| Required capital, insurance (end of period) | 38 | 37 | 41 | 38 | 37 |
| Allocated capital (end of period) | 361 | 354 | 347 | 338 | 353 |
| Return on allocated capital (ROAC) | 29% | 24% | 31% | 49% | 16% |
| Cost/income ratio, banking | 48% | 80% | 52% | 49% | 56% |
| Combined ratio, non-life insurance | 88% | 93% | 88% | 102% | 98% |
| Breakdown P&L | IFRS 9 | IFRS 9 | IAS 39 | IAS 39 | IAS 39 |
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 4Q 2017 | 3Q 2017 | 2Q 2017 |
| Net interest income | 73 | 75 | 73 | 70 | 69 |
| Non-life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Non-life | 0 | 0 | 0 | 0 | 0 |
| Technical charges Non-life | 0 | 0 | 0 | 0 | 0 |
| Life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 0 | 0 | 0 | 0 |
| Ceded reinsurance result | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 1 | -1 | 1 | 0 | 0 |
| Net realised result from available-for-sale assets | 0 | 0 | 0 | ||
| Net realised result from debt instr FV through OCI | 0 | 0 | |||
| Net fee and commission income | 0 | 0 | 0 | 0 | 0 |
| Net other income | 0 | 0 | -61 | -55 | 0 |
| TOTAL INCOME | 74 | 74 | 12 | 16 | 69 |
| Operating expenses | -49 | -51 | -59 | -43 | -42 |
| Impairment | 38 | 43 | 52 | 26 | 87 |
| on loans and receivable | 52 | 26 | 87 | ||
| on impairment on FA at AC | 39 | 43 | |||
| on available-for-sale | 0 | 0 | 0 | ||
| on impairment on FA at FV though OCI | 0 | 0 | |||
| on other | -1 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 63 | 66 | 5 | -1 | 113 |
| Income tax expense | -8 | -8 | -3 | 0 | -14 |
| RESULT AFTER TAX | 55 | 57 | 3 | -1 | 99 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 55 | 57 | 3 | -1 | 99 |
| Banking | 55 | 57 | 3 | -1 | 99 |
| Insurance | 0 | 0 | 0 | 0 | 0 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 10 592 | 10 595 | 10 694 | 10 669 | 10 648 |
| Mortgage loans (end of period) | 9 910 | 9 883 | 9 905 | 9 797 | 9 740 |
| Customer deposits and debt certificates excl. repos (end of period) | 5 540 | 5 636 | 5 392 | 5 364 | 5 385 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 5 491 | 5 496 | 6 144 | 6 525 | 6 652 |
| Allocated capital (end of period) | 582 | 583 | 639 | 679 | 692 |
| Return on allocated capital (ROAC) | 36% | 37% | 2% | -1% | 57% |
| Cost/income ratio, banking | 66% | 69% | 495% | 271% | 62% |
| Group centre - Breakdown net result | IFRS 9 | IFRS 9 | IAS 39 | IAS 39 | IAS 39 |
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 4Q 2017 | 3Q 2017 | 2Q 2017 |
| Operational costs of the Group activities | -15 | -17 | -25 | -20 | -14 |
| Capital and treasury management | 8 | -4 | -5 | 5 | 17 |
| Capital and treasury management APC | 3 | 1 | 18 | -13 | -13 |
| Results companies in rundown | 10 | 23 | -22 | 19 | 11 |
| Other | -59 | 3 | -144 | -3 | 10 |
| Total net result for the Group centre | -53 | 5 | -179 | -12 | 12 |
| Breakdown P&L | IFRS 9 | IFRS 9 | IAS 39 | IAS 39 | IAS 39 |
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2018 | 1Q 2018 | 4Q 2017 | 3Q 2017 | 2Q 2017 |
| Net interest income | 11 | 2 | -2 | 7 | 2 |
| Non-life insurance before reinsurance | 4 | 5 | 4 | 3 | 3 |
| Earned premiums Non-life | 3 | 3 | 2 | 2 | 2 |
| Technical charges Non-life | 0 | 2 | 2 | 0 | 1 |
| Life insurance before reinsurance | 0 | 0 | 0 | 0 | 2 |
| Earned premiums Life | -1 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 0 | 1 | 0 | 1 |
| Ceded reinsurance result | 1 | 0 | -1 | 1 | 0 |
| Dividend income | 4 | 1 | 1 | 1 | 6 |
| Net result from financial instruments at fair value through profit or loss | -31 | 4 | 8 | -2 | 37 |
| Net realised result from available-for-sale assets | 16 | 16 | 14 | ||
| Net realised result from debt instr FV through OCI | 8 | 0 | |||
| Net fee and commission income | -1 | -2 | -1 | -1 | -1 |
| Net other income | -37 | 1 | 3 | 5 | 2 |
| TOTAL INCOME | -43 | 11 | 29 | 30 | 63 |
| Operating expenses | -23 | -27 | -43 | -35 | -33 |
| Impairment | 4 | 16 | -6 | -6 | -11 |
| on loans and receivable | -4 | -6 | -11 | ||
| on impairment on FA at AC | 3 | 17 | |||
| on available-for-sale | 0 | 0 | 0 | ||
| on impairment on FA at FV though OCI | 1 | -1 | |||
| on other | 0 | 0 | -2 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | -61 | 0 | -20 | -11 | 18 |
| Income tax expense | 8 | 6 | -159 | -1 | -7 |
| RESULT AFTER TAX | -53 | 5 | -179 | -12 | 12 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | -53 | 5 | -179 | -12 | 12 |
| Of which banking | -18 | 9 | -166 | 6 | 17 |
| Of which holding | -38 | -7 | -10 | -20 | -7 |
| Of which insurance | 3 | 3 | -3 | 2 | 1 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repo (end of period) | 0 | 0 | 0 | 0 | 0 |
| Mortgage loans (end of period) | 0 | 0 | 0 | 0 | 0 |
| Customer deposits and debt certificates excl. repos (end of period) | 8 376 | 7 832 | 7 918 | 8 481 | 8 244 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 2 831 | 3 298 | 3 478 | 3 636 | 4 058 |
| Risk-weighted assets, insurance (end of period, Basel III fully loaded) | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | -23 | -13 | -23 | -9 | 10 |
| Allocated capital (end of period) | 277 | 336 | 339 | 369 | 432 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) | 'Consolidated income statement' | 1 248 | 2 575 | 1 485 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) | 'Consolidated statement of changes in equity' | - 33 | - 52 | - 26 |
| / | ||||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) Note 5.10 | 418 | 418 | 418 | |
| or | ||||
| Average number of ordinary shares plus dilutive options less treasury shares in the | 418 | 418 | 418 | |
| period (D) | ||||
| Basic = (A-B) / (C) (in EUR) | 2,91 | 6,03 | 3,49 | |
| Diluted = (A-B) / (D) (in EUR) | 2,91 | 6,03 | 3,49 |
Gives an insight into the technical profitability (i.e. after eliminating investment returns, among other items) of the non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio takes ceded reinsurance into account.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Net technical insurance charges, including the internal cost of settling claims (A) | Note 3.7.1 | 436 | 813 | 386 |
| / | ||||
| Net earned insurance premiums (B) | Note 3.7.1 | 756 | 1 465 | 718 |
| + | ||||
| Operating expenses (C) | Note 3.7.1 | 256 | 482 | 244 |
| / | ||||
| Net written insurance premiums (D) | Note 3.7.1 | 858 | 1 493 | 814 |
| = (A/B)+(C/D) | 87,6% | 87,8% | 83,8% |
A risk-weighted measure of the group's solvency, based on common equity tier-1 capital.
| Calculation (in millions of EUR or %) | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|
| 'Detailed calculation 'Danish compromise' table in the 'Solvency KBC Group' section.' | |||
| Fully loaded | 15,8% | 16,3% | 15,7% |
Gives an impression of the relative cost efficiency (costs relative to income) of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Operating expenses of the banking activities (A) | 'Consolidated income statement': component of 'Operating expenses' |
2 001 | 3 570 | 1 893 |
| / | ||||
| Total income of the banking activities (B) | 'Consolidated income statement': component of 'Total income' |
3 233 | 6 587 | 3 367 |
| =(A) / (B) | 61,9% | 54,2% | 56,2% |
Where relevant, we also estimate exceptional and/or non-operating items when calculating the cost/income ratio. The adjustments include: MTM ALM derivatives (fully excluded), bank taxes (including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one-off items. The Cost/Income ratio adjusted for specific items is 56,4% in 1H 2018 (versus 54,9% in FY 2017 and 52,8% in 1H 2017).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. Where appropriate, the numerator and denominator in the formula may be limited to impaired loans that are more than 90 days past due.
| Calculation (in millions of EUR or %) | Reference | (*) 1H 2018 |
2017 | 1H 2017 |
|---|---|---|---|---|
| Specific impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 403 | 4 039 | 4 968 |
| / Outstanding impaired loans (B) |
'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
9 175 | 9 186 | 10 505 |
| = (A) / (B) | 48,0% | 44,0% | 47,3% |
(*) As of 1Q18 a switch has been made in the risk reporting figures from outstanding to the new definition of gross carrying amount, i.e. including reserved and accrued interests and moreover the transaction scope of the loan portfolio has been extended. The cover ratio of FY 2017 taken into account the new definition increased from 44,0% to 48,1%.
Gives an idea of loan impairment charges recognised in the income statement for a specific period (in this case, a year), relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) | 'Consolidated income statement': component of 'Impairment' |
- 82 | - 87 | - 72 |
| / Average outstanding loan portfolio (B) |
'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
164 455 | 151 681 | 149 793 |
| = (A) (annualised) / (B) | -0,10% | -0,06% | -0,10% |
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12 and correspond to the new definition of 'nonperforming' used by the European Banking Authority.
| (*) | |||
|---|---|---|---|
| Amount outstanding of impaired loans (A) 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
9 175 | 9 186 | 10 505 |
| / Total outstanding loan portfolio (B) 'Credit risk: loan portfolio overview in the 'Credit risk' section |
166 949 | 154 160 | 152 864 |
| = (A) / (B) | 5,5% | 6,0% | 6,9% |
(*) As of 1Q18 a switch has been made in the risk reporting figures from outstanding to the new definition of gross carrying amount, i.e. including reserved and accrued interests.
In addition, the transaction scope of the loan portfolio was extended and now additionally includes the following 4 elements: (1) bank exposure (money market placements, documentary credit, accounts), (2) debtor risk KBC Commercial Finance, (3) unauthorized overdrafts, and (4) reverse repo (excl. central bank exposure). The impaired loans ratio of FY 2017 taken into account the new definition increased from 6,0% to 6,1%.
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Regulatory available tier-1 capital (A) | 'Leverage ratio KBC Group (Basel III fully loaded' table in the 'Leverage KBC Group' section |
17 115 | 16 504 | 15 731 |
| / | ||||
| Total exposure measures (total of non-risk-weighted on and off-balance sheet items, with a number of adjustments) (B) |
Based on the Capital Requirements Regulation (CRR) |
284 108 | 272 373 | 275 275 |
| = (A) / (B) | 6,0% | 6,1% | 5,7% |
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) | Based on the European Commission's | 81 089 | 79 850 | 72 800 |
| Delegated Act on LCR | ||||
| / | ||||
| Total net cash outflows over the next 30 calendar days (B) | 58 398 | 57 600 | 51 750 | |
| = (A) / (B) | 139% | 139% | 141% | |
Liquidity Coverage ratio (LCR) is based on the Delegated Act requirements. From year-end 2017 actuals, KBC discloses 12 months average LCR in accordance to EBA guidelines on LCR disclosure.
Gives an idea of the magnitude of (what are mainly pure, traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Loans and advances to customers (related to the group's banking activities) (A) | Note 4.1, component of 'Loans and advances to customers' |
145 346 | 140 999 | 137 175 |
| + | ||||
| Corporate bonds in investment books (banking) (B) | Note 4.1 component of 'debt securities - corporates' |
2 472 | - | |
| - | ||||
| Reverse repos with customers (C) | Note 4.1 | 0 | - | - |
| + Reverse repos excl Central Banks (D) |
Note 4.1, component of 'Reverse repos with credit institutions' |
2 562 | - | - |
| + | ||||
| Bank bonds in investment books (banking) ( E) | Note 4.1 component of 'debt securities - Credit institutions' |
3 607 | - | - |
| + | ||||
| Exposures on Credit institutions (incl nostro accounts) (F) | 4 839 | - | - | |
| + | ||||
| Debt instruments issued by corporates and by credit institutions and investment firms (related to the group's banking activities) (G) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions and investment firms' |
0 | 6 243 | 7 124 |
| + | ||||
| Loans and advances to credit institutions and investment firms (related to the group's banking activities, excluding dealing room activities) (H) |
Note 4.1, component of 'Loans and advances to credit institutions and investment firms ' |
0 | 881 | 1 062 |
| + | ||||
| Financial guarantees granted to clients (I) | Note 6.1, component of 'Financial guarantees | 8 200 | 8 235 | 8 135 |
| + | ||||
| Impairment on loans (J) | Note 4.2, component of 'Impairment' | 4 623 | 4 058 | 5 028 |
| - | ||||
| Insurance companies (K) | Note 4.1, component of 'Loans and advances to customers' |
- 2 118 | - 2 458 | - 828 |
| + | ||||
| Non-loan related receivables (L) | - 710 | - | - | |
| + | ||||
| Other (including accrued interest before 2018) (M) | Component of Note 4.1 | - 1 871 | - 3 797 | - 4 832 |
| = Gross carrying amount (A)+(B)-(C)+(D)+(E)+(F)+(G)+(H)+(I)+(J)-(K)+(L)+(M) | 166 949 | 154 160 | 152 864 |
As of 1Q18 a switch has been made in the risk reporting figures from 'outstanding' to the new definition of 'gross carrying amount', i.e. including reserved and accrued interests.
In addition, the transaction scope of the loan portfolio was extended and now additionally includes the following 4 elements: (1) bank exposure (money market placements, documentary credit, accounts), (2) debtor risk KBC Commercial Finance, (3) unauthorized overdrafts, and (4) reverse repo (excl. central bank exposure).
Indicates the extent to which a bank has sufficient own funds and eligible liabilities available for bail-in. MREL and bail-in are based on the idea that shareholders and debt-holders should bear losses first if a bank fails.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Own funds* and eligible liabilities (issued from KBC Group NV) (A) | Based on BRRD | 24 571 | 22 207 | 20 912 |
| / | ||||
| Risk weighted assets (consolidated, Danish compromise method) (B) | 'Consolidated balance sheet' | 92 931 | 92 410 | 91 549 |
| = (A) / (B) | 26,4% | 24,0% | 22,8% | |
* after deconsolidation of KBC Insurance
SRB's current approach to MREL is defined in the '2017 MREL Policy' published on 20 December 2017, which is based on the current legal framework and hence might be revised in the context of the ongoing legislative process to review BRRD. SRB requires KBC to achieve the MREL target by 1 May 2019, using both HoldCo and eligible OpCo instruments. From 1Q 2018 the actual MREL includes the Opco instruments.
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) (annualised) | 'Consolidated income statement': component of | 1 893 | 3 513 | 1 744 |
| 'Net interest income' | ||||
| / | ||||
| Average interest-bearing assets of the banking activities (B) | 'Consolidated balance sheet': component of | 187 526 | 187 216 | 185 640 |
| 'Total assets' | ||||
| = (A) (annualised) / (B) | 2,01% | 1,85% | 1,87% | |
From 1Q 2018 the definition of NIM has been updated, it concerns banking group NII excluding dealing room and the net positive impact of ALM FX swaps & repos.
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Basel III, the net stable funding ratio (Basel | 164 300 | 157 700 | 153 850 |
| Committee on Banking Supervision publication, | ||||
| October 2014) | ||||
| / | ||||
| Required amount of stable funding (B) | 120 750 | 117 300 | 118 300 | |
| = (A) / (B) | 136,1% | 134,5% | 130,1% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 16 616 | 17 403 | 16 665 |
| / | ||||
| Number of ordinary shares less treasury shares (at period-end) (B) | Note 5.10 | 416,2 | 418,5 | 418,4 |
| = (A) / (B) (in EUR) | 39,93 | 41,58 | 39,83 |
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| BELGIUM BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) | Note 2.1: Segment reporting based on the management structure |
680 | 1 575 | 785 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk weighted assets for the banking activities (under Basel III) and risk-weighted asset |
6 462 | 6 040 | 6 071 | |
| equivalents for the insurance activities (under Solvency II) (B) | ||||
| = (A) annualised / (B) | 21,0% | 26,1% | 25,9% | |
| CZECH REPUBLIC BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) / |
Note 2.1: Segment reporting based on the management structure |
316 | 702 | 364 |
| The average amount of capital allocated to the business unit is based on the risk weighted assets for the banking activities (under Basel III) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
1 704 | 1 620 | 1 547 | |
| = (A) annualised / (B) | 36,9% | 43,0% | 46,7% | |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) | Note 2.1: Segment reporting based on the management structure |
299 | 444 | 292 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk | 2 175 | 2 054 | 1 963 | |
| weighted assets for the banking activities (under Basel III) and risk-weighted asset | ||||
| equivalents for the insurance activities (under Solvency II) (B) | ||||
| = (A) annualised / (B) | 27,5% | 21,6% | 29,7% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) (annualised) | 'Consolidated income statement' | 1 248 | 2 575 | 1 485 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) (annualised) | 'Consolidated statement of changes in equity' | - 33 | - 52 | - 26 |
| / | ||||
| Average parent shareholders' equity, excluding the revaluation reserve for available-for | 'Consolidated statement of changes in equity' | 15 490 | 14 926 | 14 646 |
| sale / FV OCI assets / Overlay (C) | ||||
| = (A-B) (annualised) / (C) | 15,7% | 16,9% | 19,9% | |
Measures the solvency of the insurance business, calculated under Solvency II.
| Calculation | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Detailed calculation under 'Solvency II, KBC Insurance consolidated' table in the | 219% | 212% | 217% | |
| Solvency banking and insurance activities separately section |
Total assets under management (AuM) comprise third-party assets and KBC group assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The assets, therefore, consist mainly of KBC investment funds and unit-linked insurance products, assets under discretionary and advisory management mandates of (mainly retail, private banking and institutional) clients, and certain group assets. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence account for a large part of any change in this income line. In that respect, the AuM of a fund that is not sold directly to clients but is instead invested in by another fund or via a discretionary/advisory management portfolio, are also included in the total AuM figure, in view of the related work and any fee income linked to them.
| Calculation (in billions of EUR or quantity) | Reference | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 200,3 | 202,1 | 198,1 |
| + | ||||
| Czech Republic Business Unit (B) | 9,6 | 9,6 | 9,2 | |
| + | ||||
| International Markets Business Unit (C) | 4,3 | 5,0 | 5,7 | |
| A)+(B)+(C) | 214,2 | 216,7 | 213,0 | |
Note that 2017 AuM figures were reduced due to a roughly 2 billion euro adjustment in Institutional Mandates.
.
A risk-weighted measure of the group's solvency, based on total regulatory capital.
| Calculation | 1H 2018 | 2017 | 1H 2017 |
|---|---|---|---|
| Detailed calculation in the table 'Danish Compromise' under 'Solvency KBC Group' | |||
| section | |||
| Fully loaded | 20,8% | 20,2% | 19,8% |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.